@NP	OEC transplants	790
@NP	recovery of functional outcomes	816
@NP	recovery	816
@NP	functional outcomes	828
@NP	return of motor	884
@NP	return	884
@NP	motor	894
@NP	potentials	907
@NP	reduction of hindlimb hyperreflexia	925
@NP	reduction	925
@NP	hindlimb hyperreflexia	938
@NP	recovery of movements of hindlimb joints	982
@NP	recovery	982
@NP	movements of hindlimb joints	994
@NP	movements	994
@NP	hindlimb joints	1007
@NP	Axonal regeneration	1024
@NP	long axonal outgrowth of raphespinal , coerulospinal , and corticospinal tracts	1087
@NP	long axonal outgrowth	1087
@NP	raphespinal , coerulospinal , and corticospinal tracts	1112
@NP	the caudal cord stump	1172
@NP	Expression of GFAP and NG2	1195
@NP	Expression	1195
@NP	GFAP and NG2	1209
@NP	perilesional cord segments	1244
@NP	transplanted animals	1274
@NP	a more suitable environment for axonal regeneration	1307
@NP	a more suitable environment	1307
@NP	axonal regeneration	1339
@NP	earlier recovery and better functional and histological results	1369
@NP	earlier recovery	1369
@NP	rats receiving acute than delayed OEC transplants	1450
@NP	rats	1450
@NP	delayed OEC transplants	1476
@NP	The beneficial effects obtained with transplantation after transection	1501
@NP	The beneficial effects	1501
@NP	transplantation	1538
@NP	transection	1560
@NP	the application of OECs in the human injured spinal cord	1592
@NP	the application	1592
@NP	OECs in the human injured spinal cord	1611
@NP	OECs	1611
@NP	the human injured spinal cord	1619
@NP	Introduction Spinal cord transection	1651
@NP	Introduction	1651
@NP	Spinal cord transection	1664
@NP	loss of central control of motor , sensory , and autonomic functions	1699
@NP	loss	1699
@NP	central control of motor , sensory , and autonomic functions	1707
@NP	central control	1707
@NP	motor , sensory , and autonomic functions	1726
@NP	motor	1726
@NP	sensory	1733
@NP	autonomic functions	1746
@NP	the site of injury	1772
@NP	the site	1772
@NP	injury	1784
@NP	Neuronal death	1792
@NP	failure of axons to regenerate across the injury site	1821
@NP	failure	1821
@NP	axons to regenerate across the injury site	1832
@NP	the injury site	1859
@NP	permanent and irreversible deficits	1883
@NP	the patients	1922
@NP	axons	1945
@NP	the central nervous system	1976
@NP	they	2004
@NP	the ability	2016
@NP	long distances	2038
@NP	an appropriate cellular environment -LRB- David and Aguayo , 1981 -RRB-	2070
@NP	an appropriate cellular environment	2070
@NP	David and Aguayo	2107
@NP	1981	2125
@NP	Upregulation	2132
@NP	proteoglycans -LRB- Asher et al. , 2001 -RRB-	2148
@NP	proteoglycans	2148
@NP	Asher	2163
@NP	et al. , 2001	2169
@NP	et al.	2169
@NP	2001	2177
@NP	myelin associated inhibitors -LRB- Schnell and Schwab , 1990 -RRB-	2187
@NP	myelin associated inhibitors	2187
@NP	Schnell and Schwab	2217
@NP	1990	2237
@NP	lack	2244
@NP	adequate supply of neurotrophic factors	2252
@NP	adequate supply	2252
@NP	neurotrophic factors	2271
@NP	Tuszynski	2293
@NP	et al. , 1996	2303
@NP	et al.	2303
@NP	1996	2311
@NP	formation of a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2322
@NP	formation	2322
@NP	a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2335
@NP	a glial scar	2335
@NP	Fawcett and Asher	2349
@NP	1999	2368
@NP	the main factors impeding axonal regeneration	2385
@NP	the main factors	2385
@NP	axonal regeneration	2411
@NP	Transplantation of olfactory ensheathing cell -LRB- OEC -RRB-	2432
@NP	Transplantation of olfactory ensheathing cell	2432
@NP	Transplantation	2432
@NP	olfactory ensheathing cell	2451
@NP	OEC	2479
@NP	one of the experimental treatments that have provided promising results	2487
@NP	one	2487
@NP	the experimental treatments that have provided promising results	2494
@NP	the experimental treatments	2494
@NP	promising results	2541
@NP	Previous works in our laboratory	2560
@NP	Previous works	2560
@NP	our laboratory	2578
@NP	OECs transplanted into the partially injured spinal cord	2605
@NP	OECs	2605
@NP	the partially injured spinal cord	2628
@NP	functional outcome	2670
@NP	neuroprotective effects	2698
@NP	Garcı ' a-Alı ' as et al. , 2004 ; Lo ' pez-Vales et al.	2723
@NP	Garcı ' a-Alı ' as et al. , 2004	2723
@NP	Garcı ' a-Alı	2723
@NP	et al.	2738
@NP	2004	2746
@NP	Lo ' pez-Vales et al.	2752
@NP	Lo ' pez-Vales	2752
@NP	Lo '	2752
@NP	et al.	2765
@NP	2004 ; Verdu ' et al.	2773
@NP	2004	2773
@NP	Verdu ' et al.	2779
@NP	Verdu '	2779
@NP	et al.	2786
@NP	2001 , 2003	2794
@NP	2001	2794
@NP	2003	2800
@NP	the mechanisms underlying the neuroprotective/regenerative properties of OECs	2816
@NP	the mechanisms	2816
@NP	the neuroprotective/regenerative properties of OECs	2842
@NP	the neuroprotective/regenerative properties	2842
@NP	OECs	2889
@NP	modulation	2925
@NP	reactive astrocytes	2939
@NP	reduction	2963
@NP	proteoglycan expression	2976
@NP	Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001	3001
@NP	Garcı ' a-Alı ' as et al. , 2004	3001
@NP	Garcı ' a-Alı	3001
@NP	et al.	3016
@NP	2004	3024
@NP	Takami et al. , 2002	3030
@NP	Takami	3030
@NP	et al. , 2002	3037
@NP	et al.	3037
@NP	2002	3045
@NP	Verdu ' et al. , 2001	3051
@NP	Verdu '	3051
@NP	et al. , 2001	3058
@NP	et al.	3058
@NP	2001	3066
@NP	promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al.	3073
@NP	promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004	3073
@NP	promotion	3073
@NP	neoangiogenesis -LRB- Lo '	3086
@NP	neoangiogenesis	3086
@NP	Lo	3103
@NP	et al. , 2004	3116
@NP	et al.	3116
@NP	2004	3124
@NP	Ramer et al.	3130
@NP	Ramer	3130
@NP	et al.	3136
@NP	2004b	3144
@NP	release of neurotrophic factors	3156
@NP	release	3156
@NP	neurotrophic factors	3167
@NP	transplanted OECs -LRB- Woodhall et al. , 2001 -RRB-	3191
@NP	transplanted OECs	3191
@NP	Woodhall	3210
@NP	et al. , 2001	3219
@NP	et al.	3219
@NP	2001	3227
@NP	the main beneficial actions	3248
@NP	other works	3694
@NP	the regenerative and neuroprotective effects of OEC grafts	3724
@NP	the regenerative and neuroprotective effects	3724
@NP	OEC grafts	3772
@NP	spinal cord injury	3789
@NP	Andrews and Stelzner , 2004 ; Resnick et al. , 2003 ; Takami et al. , 2002	3809
@NP	Andrews and Stelzner	3809
@NP	2004 ; Resnick et al. , 2003 ; Takami et al.	3831
@NP	2004	3831
@NP	Resnick et al. , 2003 ; Takami et al.	3837
@NP	Resnick	3837
@NP	et al. , 2003 ; Takami et al.	3845
@NP	et al. , 2003	3845
@NP	et al.	3845
@NP	2003	3853
@NP	Takami et al.	3859
@NP	Takami	3859
@NP	et al.	3866
@NP	2002	3874
@NP	dorsal rhyzotomy	3883
@NP	Ramer	3901
@NP	et al. , 2004b ; Riddell et al. , 2004	3907
@NP	et al.	3907
@NP	2004b ; Riddell et al.	3915
@NP	2004b	3915
@NP	Riddell et al.	3922
@NP	Riddell	3922
@NP	et al.	3930
@NP	2004	3938
@NP	Differences	3945
@NP	cell source	3960
@NP	olfactory bulb , olfactory nerve layer or olfactory mucosa	3973
@NP	olfactory bulb	3973
@NP	olfactory nerve layer	3989
@NP	olfactory mucosa	4014
@NP	protocols for cell culturing , purification and preservation ,	4036
@NP	protocols	4036
@NP	cell culturing , purification and preservation ,	4050
@NP	cell culturing	4050
@NP	purification and preservation	4066
@NP	trauma models	4104
@NP	differences in the results	4134
@NP	differences	4134
@NP	the results	4149
@NP	current controversy	4170
@NP	several clinical trials using OECs in human spinal cord injury	4191
@NP	several clinical trials	4191
@NP	OECs in human spinal cord injury	4221
@NP	OECs	4221
@NP	human spinal cord injury	4229
@NP	ongoing -LRB- Senior , 2002 -RRB-	4258
@NP	ongoing	4258
@NP	Senior	4267
@NP	2002	4275
@NP	Utilization of OECs in human spinal cord injury	4282
@NP	Utilization	4282
@NP	OECs in human spinal cord injury	4297
@NP	OECs	4297
@NP	human spinal cord injury	4305
@NP	there	4360
@NP	no concluding experimental studies	4370
@NP	regeneration and functional recovery	4415
@NP	OECs	4464
@NP	the injured spinal cord	4487
@NP	different times postinjury	4514
@NP	Keyvan-Fouladi	4542
@NP	et al. , 2003 ; Lu et al. , 2002	4557
@NP	et al.	4557
@NP	2003 ; Lu et al.	4565
@NP	2003	4565
@NP	Lu et al.	4571
@NP	Lu	4571
@NP	et al.	4574
@NP	2002	4582
@NP	functional regeneration	4622
@NP	spinal cord injury	4652
@NP	Guth	4672
@NP	et al. , 1980	4677
@NP	et al.	4677
@NP	1980	4685
@NP	means of histological and electrophysiological methods	4712
@NP	means	4712
@NP	histological and electrophysiological methods	4721
@NP	the disconnection of nerve processes caused by the injury	4767
@NP	the disconnection	4767
@NP	nerve processes caused by the injury	4788
@NP	nerve processes	4788
@NP	the injury	4814
@NP	axonal regeneration	4841
@NP	the lesion site and postjunctional responses of regenerated fibers	4868
@NP	the lesion site	4868
@NP	postjunctional responses of regenerated fibers	4888
@NP	postjunctional responses	4888
@NP	regenerated fibers	4916
@NP	functional recovery	4960
@NP	the new connections	4993
@NP	The present study	5014
@NP	the effects of OEC grafts	5053
@NP	the effects	5053
@NP	OEC grafts	5068
@NP	axonal regeneration and target reinnervation	5082
@NP	complete thoracic spinal cord transection	5133
@NP	the adult rat	5178
@NP	immunohistochemical techniques	5236
@NP	We	5268
@NP	the regenerative properties of OECs	5285
@NP	the regenerative properties	5285
@NP	OECs	5316
@NP	they	5326
@NP	1 week	5366
@NP	spinal cord transection	5387
@NP	addition	5415
@NP	we	5425
@NP	OEC transplants	5444
@NP	the expression	5481
@NP	GFAP and NG2 , two well-known inhibitors of axonal regeneration	5499
@NP	GFAP and NG2	5499
@NP	two well-known inhibitors of axonal regeneration	5513
@NP	two well-known inhibitors	5513
@NP	axonal regeneration	5542
@NP	the central nervous system	5565
@NP	Camand et al. , 2004 ; Fawcett and Asher , 1999 ; Tang et al. , 2003	5593
@NP	Camand	5593
@NP	et al. , 2004 ; Fawcett and Asher , 1999 ; Tang et al. , 2003	5600
@NP	et al. , 2004	5600
@NP	et al.	5600
@NP	2004	5608
@NP	Fawcett and Asher , 1999	5614
@NP	Fawcett and Asher	5614
@NP	1999	5633
@NP	Tang et al. , 2003	5639
@NP	Tang	5639
@NP	et al. , 2003	5644
@NP	et al.	5644
@NP	2003	5652
@NP	Materials and methods The experimental procedures performed	5660
@NP	Materials	5660
@NP	methods The experimental procedures performed	5674
@NP	methods The experimental procedures	5674
@NP	methods	5674
@NP	The experimental procedures	5682
@NP	the recommendations of the European Union and the US Department of Health	5731
@NP	the recommendations of the European Union	5731
@NP	the recommendations	5731
@NP	the European Union	5754
@NP	the US Department of Health	5777
@NP	the US Department	5777
@NP	Health	5798
@NP	the care and use of laboratory animals	5809
@NP	the care and use	5809
@NP	laboratory animals	5829
@NP	the Ethics Committee of our institution	5869
@NP	the Ethics Committee	5869
@NP	our institution	5893
@NP	OEC cultures and immunopurification	5910
@NP	Primary olfactory bulb cultures	5946
@NP	50 P22	5995
@NP	P23 Sprague	6002
@NP	P23	6002
@NP	Sprague	6006
@NP	Dawley rats	6014
@NP	the method	6032
@NP	Gudin˜o	6056
@NP	Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB-	6065
@NP	Cabrera and Nieto-Sampedro	6065
@NP	1996	6093
@NP	2000	6099
@NP	minor modifications -LRB- Lo '	6110
@NP	minor modifications	6110
@NP	Lo	6131
@NP	pez-Vales et al.	6134
@NP	2004 ; Verdu ' et al. , 2003	6152
@NP	2004	6152
@NP	Verdu ' et al. , 2003	6158
@NP	Verdu '	6158
@NP	et al. , 2003	6165
@NP	et al.	6165
@NP	2003	6173
@NP	olfactory bulbs	6189
@NP	the meningeal layer	6219
@NP	fine forceps	6261
@NP	the bulbs	6278
@NP	The cell mixture	6343
@NP	centrifugation	6377
@NP	flasks pre-coated with poly-l-lysine -LRB- 10 Ag/ml , Sigma , St.	6406
@NP	flasks pre-coated with poly-l-lysine	6406
@NP	flasks	6406
@NP	poly-l-lysine	6429
@NP	10 Ag/ml	6444
@NP	Sigma , St.	6454
@NP	Louis , USA -RRB- .	6465
@NP	Louis	6465
@NP	USA -RRB-	6472
@NP	A defined medium	6478
@NP	the OECs	6518
@NP	confluence -LRB- 7 -- 9 days in vitro -RRB-	6543
@NP	confluence	6543
@NP	7	6555
@NP	9 days in vitro	6557
@NP	9 days	6557
@NP	vitro	6567
@NP	OECs	6575
@NP	means of magnetic Dynabeads M-450 -LRB- Dynal , Oslo , Norway -RRB-	6616
@NP	means of magnetic Dynabeads M-450	6616
@NP	means	6616
@NP	magnetic Dynabeads	6625
@NP	Dynal	6651
@NP	Oslo	6658
@NP	Norway	6664
@NP	goat anti-mouse IgG	6688
@NP	mouse	6726
@NP	monoclonal 192 IgG antibodies	6732
@NP	192	6743
@NP	MAB365	6763
@NP	Chemicon	6771
@NP	Temecula , CA	6781
@NP	the p75-NGF receptor	6810
@NP	The p75-positive OECs	6832
@NP	freezing medium -LRB- C-6295 , Sigma -RRB-	6874
@NP	freezing medium	6874
@NP	C-6295	6891
@NP	Sigma	6899
@NP	-20 °C for 10 min	6925
@NP	-20 °C	6925
@NP	10 min	6935
@NP	a deep freezer at -80 °C	6951
@NP	a deep freezer	6951
@NP	-80 °C	6969
@NP	transplantation	6980
@NP	frozen cell vials	6997
@NP	37 °C	7030
@NP	two times	7043
@NP	centrifugation	7056
@NP	900 rpm , 7 min	7072
@NP	900 rpm	7072
@NP	7 min	7081
@NP	DMEM/F12	7091
@NP	the pellet resuspended in the same medium	7105
@NP	the pellet	7105
@NP	the same medium	7131
@NP	The cells	7148
@NP	2 h of thawing	7183
@NP	2 h	7183
@NP	thawing	7190
@NP	It	7199
@NP	frozen and thawed OECs	7240
@NP	active migration and integration in the central nervous tissue	7268
@NP	active migration and integration	7268
@NP	the central nervous tissue	7304
@NP	Gudin˜o	7332
@NP	Cabrera and Nieto-Sampedro , 1996 , 2000 ; Verdu ' et al. , 2001	7340
@NP	Cabrera and Nieto-Sampedro	7340
@NP	1996	7368
@NP	2000 ; Verdu ' et al. , 2001	7374
@NP	2000	7374
@NP	Verdu ' et al. , 2001	7380
@NP	Verdu '	7380
@NP	et al. , 2001	7387
@NP	et al.	7387
@NP	2001	7395
@NP	Surgical procedure Female adult Sprague -- Dawley rats -LRB- 250 -- 300 g -RRB-	7402
@NP	Surgical procedure Female adult Sprague -- Dawley rats	7402
@NP	Surgical procedure	7402
@NP	Female adult Sprague -- Dawley rats	7421
@NP	Dawley	7442
@NP	250 -- 300 g	7455
@NP	250	7455
@NP	300 g	7459
@NP	40 mg/kg , i.p.	7504
@NP	40 mg/kg	7504
@NP	laminectomy to expose the T8 -- T9 thoracic spinal cord segments	7527
@NP	the T8 -- T9 thoracic spinal cord segments	7549
@NP	the T8	7549
@NP	T9 thoracic spinal cord segments	7556
@NP	T9	7556
@NP	thoracic spinal cord segments	7559
@NP	the cord	7590
@NP	T8	7628
@NP	microscissors	7637
@NP	The rostral and caudal stumps	7652
@NP	The rostral	7652
@NP	caudal stumps	7668
@NP	complete transection	7717
@NP	transplantation	7743
@NP	a suspension of OECs	7760
@NP	a suspension	7760
@NP	OECs	7776
@NP	a sterile glass needle -LRB- 80 µm i.d. ; 100 µm o.d. -RRB-	7815
@NP	a sterile glass needle	7815
@NP	80 µm i.d. ; 100 µm o.d.	7839
@NP	80 µm i.d.	7839
@NP	100 µm o.d.	7851
@NP	a Hamilton syringe	7877
@NP	Rats	7897
@NP	four injections of OECs -LRB- 375,000 cells in 3 µl each -RRB-	7911
@NP	four injections	7911
@NP	OECs -LRB- 375,000 cells in 3 µl each -RRB-	7930
@NP	OECs	7930
@NP	375,000 cells in 3 µl each	7936
@NP	375,000 cells	7936
@NP	3 µl each	7953
@NP	3 µl	7953
@NP	each	7958
@NP	two injections 1 mm cranial	7965
@NP	two injections	7965
@NP	1 mm cranial	7980
@NP	two 1 mm caudal	7997
@NP	the lesion epicenter	8016
@NP	each level one injection at each side 0.5 mm lateral to the cord midline	8045
@NP	each level one injection	8045
@NP	each side 0.5 mm lateral to the cord midline	8073
@NP	each side 0.5 mm lateral	8073
@NP	the cord midline	8101
@NP	0.5 mm depth -LRB- Lo ' pez-Vales et al. , 2004 -RRB-	8121
@NP	0.5 mm depth	8121
@NP	Lo ' pez-Vales et al. , 2004	8135
@NP	Lo '	8135
@NP	pez-Vales et al. , 2004	8138
@NP	et al. , 2004	8148
@NP	et al.	8148
@NP	2004	8156
@NP	Each transplanted rat	8163
@NP	a total of 1,500,000 cells	8194
@NP	a total	8194
@NP	1,500,000 cells	8205
@NP	OEC grafts	8222
@NP	30 min after the lesion -LRB- OECac group ; n = 8 -RRB-	8260
@NP	30 min	8260
@NP	the lesion -LRB- OECac group ; n = 8 -RRB-	8273
@NP	the lesion	8273
@NP	OECac group ; n = 8	8285
@NP	OECac group	8285
@NP	n = 8	8298
@NP	n	8298
@NP	8	8302
@NP	7 days -LRB- OECdl group ; n = 8 -RRB-	8317
@NP	7 days	8317
@NP	OECdl group ; n = 8	8325
@NP	OECdl group	8325
@NP	n = 8	8338
@NP	n	8338
@NP	8	8342
@NP	Control animals	8346
@NP	12 µl	8371
@NP	DMEM	8380
@NP	F12 distributed at the same	8386
@NP	F12	8386
@NP	the same	8405
@NP	30 min -LRB- DMac group ; n = 8 -RRB- or 7 days	8429
@NP	30 min -LRB- DMac group ; n = 8 -RRB-	8429
@NP	DMac group ; n = 8	8437
@NP	DMac group	8437
@NP	n = 8	8449
@NP	n	8449
@NP	8	8453
@NP	7 days	8459
@NP	postinjury -LRB- DMdl group ; n = 8 -RRB-	8466
@NP	postinjury	8466
@NP	DMdl group ; n = 8	8478
@NP	DMdl group	8478
@NP	n = 8	8490
@NP	n	8490
@NP	8	8494
@NP	All rats	8498
@NP	a 12-h light/dark cycle	8523
@NP	water and food ad libitum	8560
@NP	Bladders	8587
@NP	twice a day	8611
@NP	reflex voiding of the bladder	8629
@NP	reflex voiding	8629
@NP	the bladder	8647
@NP	Behavioral assessment Locomotor activity	8676
@NP	the open-field walking test	8737
@NP	the locomotor ability	8776
@NP	5 min	8805
@NP	One animal at a time	8812
@NP	One animal	8812
@NP	a time	8826
@NP	a circular plastic tray -LRB- 90 cm diameter x 24 cm wall height -RRB-	8867
@NP	a circular plastic tray	8867
@NP	90 cm diameter x 24 cm wall height	8892
@NP	90 cm diameter	8892
@NP	24 cm wall height	8909
@NP	Two independent examiners	8929
@NP	the hindlimb movements of the rat	8964
@NP	the hindlimb movements	8964
@NP	the rat	8990
@NP	the locomotor function	9010
@NP	the Basso	9046
@NP	Beattie	9057
@NP	Bresnahan scale	9070
@NP	BBB scale	9087
@NP	0 -LRB- paralysis -RRB-	9115
@NP	21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	9132
@NP	21 points -LRB- normal gait -RRB-	9132
@NP	21 points	9132
@NP	normal gait	9143
@NP	Basso	9157
@NP	et al. , 1995	9163
@NP	et al.	9163
@NP	1995	9171
@NP	The final score of each animal	9178
@NP	The final score	9178
@NP	each animal	9197
@NP	the mean value of both examiners	9213
@NP	the mean value	9213
@NP	examiners	9236
@NP	The climbing test	9247
@NP	voluntary hindlimb motor function -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	9291
@NP	voluntary hindlimb motor function	9291
@NP	Ramo ' n-Cueto et al. , 2000	9326
@NP	Ramo ' n-Cueto et al.	9326
@NP	Ramo ' n-Cueto	9326
@NP	Ramo '	9326
@NP	2000	9347
@NP	animals	9363
@NP	a grid -LRB- 12.5 ± 12.5 mm holes -RRB- inclined at 45 - , 60 -	9398
@NP	a grid -LRB- 12.5 ± 12.5 mm holes -RRB-	9398
@NP	a grid	9398
@NP	12.5 ± 12.5 mm holes	9406
@NP	12.5 ±	9406
@NP	12.5 mm holes	9413
@NP	45	9440
@NP	60	9445
@NP	90	9454
@NP	a horizontal platform	9473
@NP	The higher grid angle	9496
@NP	Rats	9539
@NP	the BBB score and the climbing test	9564
@NP	the BBB score	9564
@NP	the climbing test	9582
@NP	1 week	9600
@NP	injury	9613
@NP	5 months	9640
@NP	9 months	9657
@NP	Electrophysiological evaluation Electrophysiological tests	9667
@NP	all rats	9744
@NP	surgery	9762
@NP	monthly intervals until 5 months , and at 9 months postinjury	9774
@NP	monthly intervals	9774
@NP	5 months	9798
@NP	9 months	9815
@NP	postinjury	9824
@NP	Motor	9836
@NP	potentials -LRB- MEPs -RRB-	9849
@NP	potentials	9849
@NP	MEPs	9861
@NP	regeneration	9889
@NP	spinal cord descending tracts	9905
@NP	Garcı ' a-Alı ' as et al. , 2003	9936
@NP	Garcı '	9936
@NP	a-Alı ' as et al. , 2003	9942
@NP	a-Alı	9942
@NP	et al.	9951
@NP	2003	9959
@NP	MEPs	9966
@NP	supramaximal electrical stimulation	9986
@NP	single pulses of 0.1 ms	10023
@NP	single pulses	10023
@NP	0.1 ms	10040
@NP	duration and 25 mA intensity	10047
@NP	the motor cortex	10080
@NP	needle electrodes	10105
@NP	the cathode over the skull	10148
@NP	the cathode	10148
@NP	the skull	10165
@NP	the motor area and the anode	10185
@NP	the motor area	10185
@NP	the anode	10204
@NP	the nose	10217
@NP	the contralateral gastrocnemius muscle	10245
@NP	The signals	10285
@NP	the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	10340
@NP	Sapphire 4ME	10358
@NP	Vickers	10372
@NP	the amplitude	10392
@NP	the latency of the evoked potentials	10410
@NP	the latency	10410
@NP	the evoked potentials	10425
@NP	the	10425
@NP	potentials	10436
@NP	The non-invasive method applied	10448
@NP	The non-invasive method	10448
@NP	consistent evaluation of MEPs in the same animal	10487
@NP	consistent evaluation	10487
@NP	MEPs in the same animal	10512
@NP	MEPs	10512
@NP	the same animal	10520
@NP	time -LRB- Garcı ' a-Alı ' as et al. , 2003 ; Valero-Cabre ' et al. , 2004 -RRB-	10552
@NP	time	10552
@NP	Garcı ' a-Alı ' as et al. , 2003 ; Valero-Cabre ' et al. , 2004	10558
@NP	Garcı ' a-Alı ' as et al. , 2003 ; Valero-Cabre ' et al. ,	10558
@NP	Garcı ' a-Alı	10558
@NP	et al.	10573
@NP	2003 ; Valero-Cabre ' et al. ,	10581
@NP	2003	10581
@NP	Valero-Cabre ' et al.	10587
@NP	Valero-Cabre '	10587
@NP	et al.	10601
@NP	2004	10609
@NP	lumbar spinal reflexes	10626
@NP	the sciatic nerve	10650
@NP	single electrical pulses	10688
@NP	0.1-ms duration	10716
@NP	supramaximal intensity	10738
@NP	monopolar needles inserted percutaneously at the sciatic notch	10774
@NP	monopolar needles	10774
@NP	the sciatic notch	10819
@NP	Compound muscle action potentials	10838
@NP	the direct muscle response	10883
@NP	M-wave	10911
@NP	the monosynaptic reflex response	10923
@NP	H-wave	10957
@NP	the plantar muscles	10969
@NP	means of needle electrodes	11006
@NP	means	11006
@NP	needle electrodes	11015
@NP	the oscilloscope	11061
@NP	the amplitude	11089
@NP	the latency of M	11107
@NP	the latency	11107
@NP	M	11122
@NP	H-waves -LRB- Navarro et al. , 1999 ; Valero-Cabre ' et al. , 2004 -RRB-	11129
@NP	H-waves	11129
@NP	Navarro	11138
@NP	et al. , 1999 ; Valero-Cabre ' et al. , 2004	11146
@NP	et al.	11146
@NP	1999 ; Valero-Cabre ' et al.	11154
@NP	1999	11154
@NP	Valero-Cabre ' et al.	11160
@NP	Valero-Cabre '	11160
@NP	et al.	11174
@NP	2004	11182
@NP	The H/M amplitude ratio	11189
@NP	The H/M ratio	11229
@NP	spinal cord injury	11286
@NP	Malmsten , 1983 ; Valero-Cabre ' et al. , 2004	11306
@NP	Malmsten	11306
@NP	1983 ; Valero-Cabre ' et al.	11316
@NP	1983	11316
@NP	Valero-Cabre ' et al.	11322
@NP	Valero-Cabre '	11322
@NP	et al.	11336
@NP	2004	11344
@NP	H-reflex facilitation	11362
@NP	interruption of supraspinal motor control	11391
@NP	interruption	11391
@NP	supraspinal motor control	11407
@NP	the corticospinal tract	11445
@NP	corticospinal axons	11487
@NP	the lesion site	11538
@NP	the corticospinal tract	11555
@NP	biotin dextran amine	11610
@NP	BDA ; 10,000 MW ; Molecular Probes	11632
@NP	BDA	11632
@NP	10,000 MW ; Molecular Probes	11637
@NP	10,000 MW	11637
@NP	Molecular Probes	11648
@NP	Eugene , OR	11666
@NP	Eugene	11666
@NP	OR	11674
@NP	9 months after injury	11682
@NP	9 months	11682
@NP	injury	11697
@NP	rats	11705
@NP	anesthetized , placed in a stereotaxic frame	11715
@NP	anesthetized	11715
@NP	a stereotaxic frame	11739
@NP	two holes	11764
@NP	the cranium	11792
@NP	both sensorimotor cortices	11814
@NP	a single injection	11848
@NP	hemisphere	11871
@NP	1 Al of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11885
@NP	1 Al	11885
@NP	a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11893
@NP	a 10 % BDA solution	11893
@NP	0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11915
@NP	0.01 M phosphate buffer	11915
@NP	pH 7.2	11940
@NP	0.5 mm caudal and 2.5 mm lateral	11960
@NP	0.5 mm caudal	11960
@NP	2.5 mm lateral	11978
@NP	bregma	11998
@NP	a depth	12009
@NP	1.5 mm	12020
@NP	skull surface	12032
@NP	a 10-Al Hamilton syringe	12053
@NP	place for 2 min	12095
@NP	place	12095
@NP	2 min	12105
@NP	injection -LRB- Schucht et al. , 2002 -RRB-	12117
@NP	injection	12117
@NP	Schucht	12128
@NP	et al. , 2002	12136
@NP	et al.	12136
@NP	2002	12144
@NP	BDA-labeled corticospinal axons	12151
@NP	Cy2 or Cy3	12208
@NP	avidin	12230
@NP	biotin complex -LRB- 1:200 , Jackson Immunoresearch , West Grove , PA -RRB-	12237
@NP	biotin complex	12237
@NP	1:200 , Jackson Immunoresearch , West Grove , PA	12253
@NP	1:200	12253
@NP	Jackson Immunoresearch	12260
@NP	West Grove	12284
@NP	PA	12296
@NP	Histological evaluation Two weeks following BDA injection , rats	12301
@NP	Histological evaluation Two weeks	12301
@NP	BDA injection , rats	12345
@NP	BDA injection	12345
@NP	rats	12360
@NP	4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	12399
@NP	4 % paraformaldehyde	12399
@NP	0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	12422
@NP	0.1 M phosphate buffer	12422
@NP	pH 7.4	12446
@NP	Spinal cord	12455
@NP	T6 -- T10 , T10 -- T13 , and L1 -- S6 were removed	12479
@NP	T6	12479
@NP	T10 , T10 -- T13 , and L1	12482
@NP	T10	12482
@NP	T10 -- T13	12487
@NP	T10	12487
@NP	T13	12491
@NP	L1	12500
@NP	S6	12503
@NP	post-fixed overnight in the same fixative , and cryoprotected in 30 % sucrose	12520
@NP	the same fixative	12544
@NP	30 %	12584
@NP	4-C	12599
@NP	Spinal cord segments	12604
@NP	TissueTek -LRB- Sakumura , Netherlands -RRB- , cut	12642
@NP	Sakumura	12653
@NP	Netherlands	12663
@NP	the sagital plane	12693
@NP	15	12712
@NP	thickness	12718
@NP	a cryostat	12732
@NP	gelatin-coated glass slides	12763
@NP	several washes with trizma-buffer saline -LRB- TBS , 0.1 M , pH 7.4 -RRB-	12798
@NP	several washes	12798
@NP	trizma-buffer saline -LRB- TBS , 0.1 M , pH 7.4 -RRB-	12818
@NP	trizma-buffer saline	12818
@NP	TBS	12840
@NP	0.1 M	12845
@NP	pH 7.4	12852
@NP	sections	12861
@NP	TBS with 0.5 % Triton X-100 -LRB- Fluka , Madrid , Spain -RRB-	12888
@NP	TBS	12888
@NP	0.5 % Triton X-100 -LRB- Fluka , Madrid , Spain -RRB-	12897
@NP	0.5 % Triton X-100	12897
@NP	Fluka	12916
@NP	Madrid	12923
@NP	Spain	12931
@NP	5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h and then overnight	12942
@NP	5 % FCS -LRB- Biological Industries , Israel -RRB-	12942
@NP	5 % FCS	12942
@NP	Biological Industries , Israel	12950
@NP	Biological Industries	12950
@NP	Israel	12973
@NP	1 h and then overnight	12985
@NP	1 h	12985
@NP	then overnight	12993
@NP	4 °C with primary antibodies	13011
@NP	4 °C	13011
@NP	primary antibodies	13020
@NP	washes	13682
@NP	sections	13690
@NP	Cy2 or Cy3	13719
@NP	immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB- for 3 h	13741
@NP	immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	13741
@NP	immunoglobulin G	13741
@NP	1:200	13759
@NP	Jackson Immunoresearch	13766
@NP	3 h	13794
@NP	room temperature	13801
@NP	additional washes with TBS	13829
@NP	additional washes	13829
@NP	TBS	13852
@NP	sections	13857
@NP	ethanol	13885
@NP	DPX -LRB- Fluka -RRB-	13915
@NP	DPX	13915
@NP	Fluka	13920
@NP	negative controls	13932
@NP	some sections	13951
@NP	the omission of primary antibodies	13998
@NP	the omission	13998
@NP	primary antibodies	14014
@NP	Images occupying most of the dorso-ventral axis of the spinal cord	14034
@NP	Images	14034
@NP	most of the dorso-ventral axis of the spinal cord	14051
@NP	most	14051
@NP	the dorso-ventral axis of the spinal cord	14059
@NP	the dorso-ventral axis	14059
@NP	the spinal cord	14085
@NP	200x magnification	14115
@NP	the lesion epicenter	14139
@NP	GFAP staining due to lack of labeling in this region	14172
@NP	GFAP staining	14172
@NP	lack of labeling in this region	14193
@NP	lack	14193
@NP	labeling in this region	14201
@NP	labeling	14201
@NP	this region	14213
@NP	1 mm cranial and 1 mm caudal	14238
@NP	1 mm cranial	14238
@NP	1 mm caudal	14255
@NP	the lesion edge	14270
@NP	Images	14287
@NP	the aid	14310
@NP	a digital camera -LRB- Olympus DP50 -RRB-	14321
@NP	a digital camera	14321
@NP	Olympus DP50	14339
@NP	the microscope and then	14365
@NP	the microscope	14365
@NP	then	14384
@NP	NIH Image software for Apple Computers -LRB- version 1.6 -RRB-	14405
@NP	NIH Image software	14405
@NP	Apple Computers -LRB- version 1.6 -RRB-	14428
@NP	Apple Computers	14428
@NP	version 1.6	14445
@NP	Fiber quantification	14459
@NP	the number	14508
@NP	pixels	14522
@NP	fibers per area -LRB- µm2 -RRB-	14549
@NP	fibers	14549
@NP	area -LRB- µm2 -RRB-	14560
@NP	area	14560
@NP	µm2	14566
@NP	a threshold for background correction -LRB- Bradburry et al. , 1999 -RRB-	14586
@NP	a threshold	14586
@NP	background correction -LRB- Bradburry et al. , 1999 -RRB-	14602
@NP	background correction	14602
@NP	Bradburry	14625
@NP	et al. , 1999	14635
@NP	et al.	14635
@NP	1999	14643
@NP	GFAP and NG2 staining quantification	14654
@NP	the intensity	14692
@NP	a scale	14729
@NP	0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14745
@NP	0	14745
@NP	no fluorescence	14748
@NP	255	14769
@NP	maximal fluorescence	14774
@NP	Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2001	14810
@NP	Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. ,	14810
@NP	Garcı ' a-Alı	14810
@NP	et al.	14825
@NP	2004 ; Plant et al. ,	14833
@NP	2004	14833
@NP	Plant et al.	14839
@NP	Plant	14839
@NP	et al.	14845
@NP	2001	14853
@NP	quantitative analysis	14864
@NP	series	14887
@NP	eight spinal cord sections -LRB- 15 µm thick -RRB- separated by 135-µm intervals	14897
@NP	eight spinal cord sections	14897
@NP	15 µm	14925
@NP	135-µm intervals	14951
@NP	the above-indicated markers in each rat	14987
@NP	the above-indicated markers	14987
@NP	each rat	15018
@NP	each animal	15032
@NP	the immunoreactivity degree per marker	15045
@NP	the immunoreactivity degree	15045
@NP	marker	15077
@NP	the mean obtained in 12 serial sections	15088
@NP	the mean	15088
@NP	12 serial sections	15109
@NP	each group	15139
@NP	a mean value	15151
@NP	the average of each animal value	15182
@NP	the average	15182
@NP	each animal value	15197
@NP	variability	15235
@NP	sections from the different groups	15248
@NP	sections	15248
@NP	the different groups	15262
@NP	each marker	15317
@NP	the setting for image acquisition	15334
@NP	the setting	15334
@NP	image acquisition	15350
@NP	the same for all the images	15372
@NP	the same	15372
@NP	all the images	15385
@NP	Statistical analysis Functional	15401
@NP	electrophysiological , and histological measurements	15434
@NP	a blinded manner regarding the treatment received by each rat	15504
@NP	a blinded manner	15504
@NP	the treatment received by each rat	15531
@NP	the treatment	15531
@NP	each rat	15557
@NP	Data	15567
@NP	the mean T SEM	15589
@NP	Statistical comparisons between groups	15605
@NP	Statistical comparisons	15605
@NP	groups	15637
@NP	nonparametric Kruskal -- Wallis and Mann -- Whitney	15657
@NP	Wallis and Mann	15679
@NP	U tests	15703
@NP	Differences	15712
@NP	P	15755
@NP	Regression analysis	15765
@NP	relationships	15802
@NP	electrophysiological and functional results	15824
@NP	functional and histological results	15880
@NP	individual animals	15921
@NP	Chi-square analysis	15941
@NP	the proportion of rats showing MEPs restitution in each group	15981
@NP	the proportion	15981
@NP	rats showing MEPs restitution in each group	15999
@NP	rats	15999
@NP	MEPs restitution in each group	16012
@NP	MEPs restitution	16012
@NP	each group	16032
@NP	Results	16045
@NP	Table 1 Results of the amplitude of MEPs	16053
@NP	Table 1 Results	16053
@NP	the amplitude of MEPs	16072
@NP	the amplitude	16072
@NP	MEPs	16089
@NP	the gastrocnemius muscle	16106
@NP	M	16139
@NP	plantar muscles	16166
@NP	electrophysiological tests	16191
@NP	injury	16235
@NP	9 months after spinal cord transection in the different experimental groups Fig.	16249
@NP	9 months	16249
@NP	spinal cord transection in the different experimental groups Fig.	16264
@NP	spinal cord transection	16264
@NP	the different experimental groups Fig.	16291
@NP	1	16331
@NP	Representative electrophysiological recordings	16334
@NP	MEPs	16384
@NP	intact animals -LRB- A -RRB-	16392
@NP	intact animals	16392
@NP	A	16408
@NP	spinal cord	16418
@NP	transected animals -LRB- B -- F -RRB-	16430
@NP	transected animals	16430
@NP	B -- F	16450
@NP	B	16450
@NP	F	16453
@NP	the change of vertical scale in recording A and recordings B -- F.	16462
@NP	the change	16462
@NP	vertical scale in recording A and recordings B -- F.	16476
@NP	vertical scale	16476
@NP	recording A and recordings B -- F.	16494
@NP	recording A and recordings B	16494
@NP	F.	16523
@NP	injury	16532
@NP	MEPs	16540
@NP	the 9-month follow-up in DM-injected animals -LRB- B -RRB-	16583
@NP	the 9-month follow-up	16583
@NP	DM-injected animals -LRB- B -RRB-	16608
@NP	DM-injected animals	16608
@NP	B	16629
@NP	Representative MEPs	16633
@NP	first	16658
@NP	one OECac rat at 2 months postlesion -LRB- C -RRB-	16677
@NP	one OECac rat	16677
@NP	2 months postlesion -LRB- C -RRB-	16694
@NP	2 months postlesion	16694
@NP	C	16715
@NP	one OECdl rat at 3 months -LRB- D -RRB-	16725
@NP	one OECdl rat	16725
@NP	3 months -LRB- D -RRB-	16742
@NP	3 months	16742
@NP	D	16752
@NP	9 months	16763
@NP	injury in rats of group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16782
@NP	injury	16782
@NP	rats of group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16792
@NP	rats	16792
@NP	group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16800
@NP	group OECac	16800
@NP	E	16813
@NP	group OECdl	16820
@NP	F	16833
@NP	Plot graphs	16837
@NP	the evolution	16854
@NP	the amplitude -LRB- G -RRB- and the latency -LRB- H -RRB-	16871
@NP	the amplitude	16871
@NP	G	16886
@NP	the latency	16893
@NP	H	16906
@NP	MEPs	16912
@NP	Fig. 2 .	16919
@NP	Fig.	16919
@NP	2	16924
@NP	Representative electrophysiological recordings of M - and H-waves	16927
@NP	Representative electrophysiological recordings	16927
@NP	M	16977
@NP	stimulation of the sciatic nerve in intact and spinal cord transected animals	17002
@NP	stimulation	17002
@NP	the sciatic nerve in intact and spinal cord transected animals	17017
@NP	the sciatic nerve	17017
@NP	intact and spinal cord transected animals	17038
@NP	spinal cord	17049
@NP	the increase of the H-wave amplitude in injured rats , more marked	17086
@NP	the increase	17086
@NP	the H-wave amplitude in injured rats	17102
@NP	the H-wave amplitude	17102
@NP	injured rats	17126
@NP	DM-injected groups	17155
@NP	OEC-transplanted groups -LRB- A -RRB-	17182
@NP	OEC-transplanted groups	17182
@NP	A	17207
@NP	Plot showing the evolution of the H/M amplitude ratio over time -LRB- B -RRB- .	17211
@NP	Plot	17211
@NP	the evolution of the H/M amplitude ratio over time -LRB- B -RRB-	17224
@NP	the evolution	17224
@NP	the H/M amplitude ratio over time -LRB- B -RRB-	17241
@NP	the H/M amplitude ratio	17241
@NP	time -LRB- B -RRB-	17270
@NP	time	17270
@NP	B	17276
@NP	Plots	17280
@NP	the BBB score	17289
@NP	time	17308
@NP	spinal cord transection	17319
@NP	all the rats in each experimental group -LRB- C -RRB-	17347
@NP	all the rats	17347
@NP	each experimental group -LRB- C -RRB-	17363
@NP	each experimental group	17363
@NP	C	17388
@NP	the rats	17400
@NP	the rats that did not recover MEPs in OECac and OECdl groups	17431
@NP	the rats	17431
@NP	MEPs	17461
@NP	OECac and OECdl groups	17469
@NP	D	17493
@NP	P values	17497
@NP	P <	17508
@NP	P	17508
@NP	<	17510
@NP	0.05 , **	17512
@NP	0.05	17512
@NP	0.01	17524
@NP	group DMac	17541
@NP	# P < 0.05 , ## P < 0.01 compared to group DMdl ; $ P <	17553
@NP	# P < 0.05 , ## P < 0.01 compared to group DMdl	17553
@NP	# P <	17553
@NP	0.05 , ## P <	17558
@NP	0.05	17558
@NP	## P	17564
@NP	0.01 compared to group DMdl	17570
@NP	0.01	17570
@NP	group DMdl	17587
@NP	$ P <	17599
@NP	$ P	17599
@NP	<	17602
@NP	0.05 compared to group OECdl	17604
@NP	0.05	17604
@NP	group OECdl	17621
@NP	Fig. 3 .	17635
@NP	Fig.	17635
@NP	3	17640
@NP	Representative macroscopic images of completely	17643
@NP	Representative macroscopic images	17643
@NP	spinal cords	17702
@NP	9.5 months after injury	17718
@NP	9.5 months	17718
@NP	injury	17735
@NP	DMac -LRB- A -RRB-	17747
@NP	DMac	17747
@NP	A	17753
@NP	DMdl -LRB- B -RRB-	17757
@NP	DMdl	17757
@NP	B	17763
@NP	OECac -LRB- C -RRB-	17767
@NP	OECac	17767
@NP	C	17774
@NP	OECdl groups -LRB- D -RRB-	17782
@NP	OECdl groups	17782
@NP	D	17796
@NP	Arrows	17800
@NP	the transection site	17816
@NP	cranial	17838
@NP	the left	17852
@NP	DM groups -LRB- A , B -RRB-	17875
@NP	DM groups	17875
@NP	A , B	17886
@NP	A	17886
@NP	B	17889
@NP	there	17893
@NP	a translucent tissue with a dark background at the site of transection	17902
@NP	a translucent tissue	17902
@NP	a dark background at the site of transection	17928
@NP	a dark background	17928
@NP	the site of transection	17949
@NP	the site	17949
@NP	transection	17961
@NP	contrast	17977
@NP	spinal cords from OEC groups -LRB- C , D -RRB-	17990
@NP	spinal cords	17990
@NP	OEC groups -LRB- C , D -RRB-	18008
@NP	OEC groups	18008
@NP	the site of transection	18027
@NP	the site	18027
@NP	transection	18039
@NP	a whitish tissue	18065
@NP	all the images	18087
@NP	cranial	18103
@NP	the left and caudal at the right	18117
@NP	the left and caudal	18117
@NP	the right	18140
@NP	dorsal	18151
@NP	the top and ventral	18164
@NP	the bottom of the image	18187
@NP	the bottom	18187
@NP	the image	18201
@NP	Scale	18212
@NP	5 mm	18224
@NP	Fig. 4 .	18231
@NP	Fig.	18231
@NP	4	18236
@NP	Microscopic image of a transected spinal cord	18239
@NP	Microscopic image	18239
@NP	a transected spinal cord	18260
@NP	GFAP showing absence of GFAP-positive tissue at the transection site	18307
@NP	GFAP	18307
@NP	absence of GFAP-positive tissue	18320
@NP	absence	18320
@NP	GFAP-positive tissue	18331
@NP	the transection site	18355
@NP	GFAP labeling	18391
@NP	the surrounding cord	18412
@NP	parenchyma -LRB- A ; same orientation as in Fig. 3 -RRB-	18433
@NP	parenchyma	18433
@NP	A ; same orientation as in Fig. 3	18445
@NP	A	18445
@NP	same orientation as in Fig. 3	18448
@NP	same orientation as	18448
@NP	Fig. 3	18471
@NP	High-magnification image from the epicenter lesion of the same spinal cord	18480
@NP	High-magnification image	18480
@NP	the epicenter lesion of the same spinal cord	18510
@NP	the epicenter lesion	18510
@NP	the same spinal cord	18534
@NP	the presence of GAP-43-immunoreactive axons	18563
@NP	the presence	18563
@NP	GAP-43-immunoreactive axons	18579
@NP	the transection site -LRB- B -RRB-	18614
@NP	the transection site	18614
@NP	B	18636
@NP	Histogram graphs	18640
@NP	the degree of immunoreactivity	18660
@NP	the degree	18660
@NP	immunoreactivity	18674
@NP	NF200 -LRB- C -RRB- , GAP-43 -LRB- D -RRB- , and CGRP -LRB- E -RRB-	18699
@NP	NF200 -LRB- C -RRB-	18699
@NP	NF200	18699
@NP	C	18706
@NP	GAP-43 -LRB- D -RRB-	18710
@NP	GAP-43	18710
@NP	D	18718
@NP	CGRP -LRB- E -RRB-	18726
@NP	CGRP	18726
@NP	E	18732
@NP	cranial , epicenter , and caudal regions of the injured spinal cords	18738
@NP	cranial	18738
@NP	epicenter	18747
@NP	caudal regions of the injured spinal cords	18762
@NP	caudal regions	18762
@NP	the injured spinal cords	18780
@NP	Spinal cord section	18806
@NP	one OECactransplanted rat	18829
@NP	CGRP-positive axons	18863
@NP	the dorsal funiculi at the cranial stump edge -LRB- F -RRB-	18888
@NP	the dorsal funiculi	18888
@NP	the cranial stump edge -LRB- F -RRB-	18911
@NP	the cranial stump edge	18911
@NP	F	18935
@NP	P <	18940
@NP	P	18940
@NP	<	18942
@NP	0.05	18944
@NP	P	18952
@NP	< 0.01 , *** P <	18954
@NP	< 0.01	18954
@NP	<	18954
@NP	0.01	18956
@NP	*** P	18962
@NP	0.001 compared to group DMac ; # P < 0.05	18969
@NP	0.001 compared to group DMac	18969
@NP	0.001	18969
@NP	group DMac	18987
@NP	# P < 0.05	18999
@NP	# P <	18999
@NP	0.05	19004
@NP	## P <	19010
@NP	0.01 , ### P <	19016
@NP	0.01	19016
@NP	### P	19022
@NP	0.001 compared to group DMdl	19029
@NP	0.001	19029
@NP	group DMdl	19047
@NP	Scale bar	19059
@NP	1000 µm in panel A , 150 µm in panel B , and 100 µm in panel E.	19076
@NP	1000 µm in panel A	19076
@NP	1000 µm	19076
@NP	panel A	19087
@NP	150 µm in panel B	19096
@NP	150 µm	19096
@NP	panel B	19106
@NP	100 µm in panel E.	19119
@NP	100 µm	19119
@NP	panel E.	19129
@NP	Fig. 5 .	19139
@NP	Fig.	19139
@NP	5	19144
@NP	Histogram graph	19147
@NP	the degree of reactivity	19166
@NP	the degree	19166
@NP	reactivity	19180
@NP	BDA , serotonin , and DhOH-positive axons	19194
@NP	BDA	19194
@NP	serotonin	19199
@NP	DhOH-positive axons	19214
@NP	cranial	19237
@NP	epicenter	19246
@NP	caudal regions of the transected spinal cord -LRB- A -RRB-	19261
@NP	caudal regions	19261
@NP	the transected spinal cord -LRB- A -RRB-	19279
@NP	the transected spinal cord	19279
@NP	A	19307
@NP	Micrographs	19311
@NP	corticospinal -LRB- B -RRB-	19326
@NP	raphespinal -LRB- C -RRB-	19345
@NP	coerulospinal	19366
@NP	D	19381
@NP	axons	19396
@NP	the transection site -LRB- arrows -RRB- of the spinal cord of an OECac rat	19409
@NP	the transection site -LRB- arrows -RRB-	19409
@NP	the transection site	19409
@NP	arrows	19431
@NP	the spinal cord of an OECac rat	19442
@NP	the spinal cord	19442
@NP	an OECac rat	19461
@NP	Micrographs	19475
@NP	corticospinal -LRB- E , H -RRB-	19490
@NP	corticospinal	19490
@NP	E , H	19505
@NP	E	19505
@NP	H	19508
@NP	raphespinal -LRB- F , I -RRB-	19512
@NP	raphespinal	19512
@NP	F	19525
@NP	I	19528
@NP	coerulospinal -LRB- G , J -RRB-	19536
@NP	coerulospinal	19536
@NP	axons	19569
@NP	T11	19587
@NP	the white -LRB- E -- G -RRB- and gray -LRB- H -- J -RRB- matter	19607
@NP	E -- G	19618
@NP	E	19618
@NP	G	19620
@NP	H -- J	19633
@NP	H	19633
@NP	J	19636
@NP	arrows	19647
@NP	a rat of group OECac	19658
@NP	a rat	19658
@NP	group OECac	19667
@NP	all the images	19684
@NP	cranial	19700
@NP	the left and caudal at the right	19714
@NP	the left and caudal	19714
@NP	the right	19737
@NP	dorsal	19748
@NP	the top and ventral	19761
@NP	the bottom of the image	19784
@NP	the bottom	19784
@NP	the image	19798
@NP	P <	19810
@NP	P	19810
@NP	<	19812
@NP	0.05	19814
@NP	P	19822
@NP	<	19824
@NP	0.01 compared to group DMac ; # P < 0.05 , ## P <	19826
@NP	0.01	19826
@NP	group DMac ; # P < 0.05 , ## P <	19843
@NP	group DMac ; # P < 0.05	19843
@NP	group DMac	19843
@NP	# P < 0.05	19855
@NP	# P <	19855
@NP	0.05	19860
@NP	## P	19866
@NP	0.01 compared to group DMdl	19872
@NP	0.01	19872
@NP	group DMdl	19889
@NP	$ P < 0.05	19901
@NP	P	19902
@NP	0.05	19906
@NP	group OECdl	19923
@NP	Scale	19936
@NP	100 µm	19948
@NP	Fig. 6 .	19957
@NP	Fig.	19957
@NP	6	19962
@NP	Micrographs	19965
@NP	corticospinal -LRB- A -RRB-	19980
@NP	raphespinal -LRB- B -RRB-	19999
@NP	coerulospinal -LRB- C -RRB-	20020
@NP	coerulospinal	20020
@NP	C	20035
@NP	fibers -LRB- in red -RRB-	20038
@NP	fibers	20038
@NP	the lumbar motoneurons	20063
@NP	ChAT	20109
@NP	green ; arrows	20118
@NP	green	20118
@NP	arrows	20125
@NP	some regenerated axons	20144
@NP	close contact	20177
@NP	ChAT-immunoreactive motoneurons -LRB- insert -RRB-	20196
@NP	ChAT-immunoreactive motoneurons	20196
@NP	insert	20229
@NP	High-power magnification	20238
@NP	NG2-immunoreactive cells -LRB- D -RRB- and GAP-43-positive axons -LRB- E -RRB-	20266
@NP	NG2-immunoreactive cells	20266
@NP	D	20292
@NP	GAP-43-positive axons	20299
@NP	E	20322
@NP	the lesion epicenter	20332
@NP	Double staining	20354
@NP	GAP-43-labeled profiles	20381
@NP	their growing orientation	20413
@NP	NG2-immunoreactive cells -LRB- F -RRB-	20460
@NP	NG2-immunoreactive cells	20460
@NP	F	20486
@NP	Scale	20490
@NP	100 µm	20502
@NP	Fig. 7 .	20511
@NP	Fig.	20511
@NP	7	20516
@NP	Histogram	20519
@NP	the degree	20532
@NP	immunoreactivity	20546
@NP	NG2 -LRB- A -RRB- and GFAP -LRB- B -RRB-	20571
@NP	NG2	20571
@NP	A	20576
@NP	GFAP	20583
@NP	B	20589
@NP	9.5 months	20595
@NP	injury in all experimental groups	20616
@NP	injury	20616
@NP	all experimental groups	20626
@NP	Representative	20651
@NP	high-power magnification images of reactive astrocytes from DMac -LRB- C -RRB-	20666
@NP	high-power magnification images	20666
@NP	reactive astrocytes from DMac	20701
@NP	reactive astrocytes	20701
@NP	DMac	20726
@NP	C	20732
@NP	DMdl -LRB- D -RRB-	20736
@NP	DMdl	20736
@NP	D	20742
@NP	OECac -LRB- E -RRB-	20746
@NP	OECac	20746
@NP	E	20753
@NP	OECdl -LRB- F -RRB- groups	20761
@NP	OECdl	20761
@NP	F	20768
@NP	groups	20771
@NP	Astrocytes from OEC-transplanted rats , especially from group OECac ,	20779
@NP	Astrocytes from OEC-transplanted rats	20779
@NP	Astrocytes	20779
@NP	OEC-transplanted rats	20795
@NP	group OECac	20834
@NP	lesser hyperthophic morphology with thinner processes	20852
@NP	lesser hyperthophic morphology	20852
@NP	thinner processes	20888
@NP	a more aligned network	20916
@NP	DM-injected animals	20947
@NP	P <	20969
@NP	P	20969
@NP	<	20971
@NP	0.05	20973
@NP	P	20981
@NP	<	20983
@NP	0.01 , *** P <	20985
@NP	0.01	20985
@NP	*** P	20991
@NP	0.001 compared to group DMac	20998
@NP	0.001	20998
@NP	group DMac	21016
@NP	# P < 0.05 , ## P < 0.01 , ### P < 0.001 compared to group DMdl	21028
@NP	# P <	21028
@NP	0.05 , ## P < 0.01 , ### P <	21033
@NP	0.05 , ## P < 0.01 ,	21033
@NP	0.05	21033
@NP	## P < 0.01	21039
@NP	## P <	21039
@NP	0.01	21045
@NP	### P	21051
@NP	0.001 compared to group DMdl	21058
@NP	0.001	21058
@NP	group DMdl	21076
@NP	$ $ P < 0.01	21088
@NP	$ $ P <	21088
@NP	0.01	21094
@NP	group OECdl	21111
@NP	Scale	21124
@NP	50 µm	21136
@NP	All animals	21144
@NP	injury	21175
@NP	2 animals of group OECdl and 1 rat of group DMdl	21187
@NP	2 animals of group OECdl	21187
@NP	2 animals	21187
@NP	group OECdl	21200
@NP	1 rat of group DMdl	21216
@NP	1 rat	21216
@NP	group DMdl	21225
@NP	the second surgery for delayed transplantation	21248
@NP	the second surgery	21248
@NP	delayed transplantation	21271
@NP	There	21296
@NP	a loss of about 30 -- 40 % in the animals ' body weight	21306
@NP	a loss of about 30	21306
@NP	a loss	21306
@NP	30	21322
@NP	40 % in the animals ' body weight	21325
@NP	40 %	21325
@NP	the animals ' body weight	21332
@NP	the animals '	21332
@NP	the first week after spinal cord transection	21364
@NP	the first week	21364
@NP	spinal cord transection	21385
@NP	rats	21422
@NP	weight	21440
@NP	values	21456
@NP	9 months of 124 ± 6 % , 117 ± 9 % , 138 ± 9 % , and 130 ± 6 %	21466
@NP	9 months	21466
@NP	124 ± 6 % , 117 ± 9 % , 138 ± 9 % , and 130 ± 6 %	21478
@NP	124 ± 6 %	21478
@NP	124 ±	21478
@NP	6 %	21484
@NP	117 ± 9 %	21488
@NP	117 ±	21488
@NP	9 %	21494
@NP	138 ± 9 %	21498
@NP	138 ±	21498
@NP	9 %	21504
@NP	130 ± 6 %	21512
@NP	130 ±	21512
@NP	respect	21526
@NP	preoperative weight in groups DMac , DMdl , OECac , and OECdl , respectively	21537
@NP	preoperative weight in groups DMac , DMdl , OECac ,	21537
@NP	preoperative weight	21537
@NP	groups DMac , DMdl , OECac ,	21560
@NP	OECdl , respectively	21590
@NP	OECdl	21590
@NP	One or two rats from each group	21611
@NP	One or two rats	21611
@NP	each group	21632
@NP	due to breast tumors after 6 months follow-up	21667
@NP	breast tumors after 6 months	21674
@NP	breast tumors	21674
@NP	6 months	21694
@NP	The numbers of surviving animals at the end of the study	21714
@NP	The numbers	21714
@NP	surviving animals at the end of the study	21729
@NP	surviving animals	21729
@NP	the end of the study	21750
@NP	the end	21750
@NP	the study	21761
@NP	7 , 5 , 6 , and 5 in DMac , DMdl , OECac , and OECdl groups ,	21776
@NP	7	21776
@NP	5 , 6 , and 5 in DMac , DMdl , OECac ,	21779
@NP	5 , 6 , and 5	21779
@NP	DMac , DMdl , OECac ,	21794
@NP	OECdl groups	21817
@NP	Electrophysiological results MEPs	21845
@NP	a latency of about 6 ms and amplitude of 8 -- 10 mV	21884
@NP	a latency	21884
@NP	6 ms and amplitude of 8 -- 10 mV	21903
@NP	6 ms	21903
@NP	amplitude of 8	21912
@NP	amplitude	21912
@NP	8	21925
@NP	10 mV	21927
@NP	the gastrocnemius muscle of intact animals	21952
@NP	the gastrocnemius muscle	21952
@NP	intact animals	21980
@NP	Fig. 1A	21996
@NP	Table	22009
@NP	spinal cord transection	22025
@NP	MEPs	22050
@NP	the 9 months in DM-injected animals	22097
@NP	the 9 months	22097
@NP	DM-injected animals	22113
@NP	complete interruption of spinal motor pathways -LRB- Fig. 1B -RRB-	22145
@NP	complete interruption	22145
@NP	spinal motor pathways -LRB- Fig. 1B -RRB-	22170
@NP	spinal motor pathways	22170
@NP	Fig. 1B	22193
@NP	contrast	22206
@NP	4 of 6 animals of group OECac	22216
@NP	4	22216
@NP	6 animals of group OECac	22221
@NP	6 animals	22221
@NP	group OECac	22234
@NP	recovery of MEPs starting by 2	22253
@NP	recovery	22253
@NP	MEPs starting by 2	22265
@NP	MEPs	22265
@NP	2	22282
@NP	3 months and 4 of 5 animals of group OECdl by 3	22284
@NP	3 months	22284
@NP	4 of 5 animals of group OECdl by 3	22297
@NP	4	22297
@NP	5 animals of group OECdl by 3	22302
@NP	5 animals	22302
@NP	group OECdl by 3	22315
@NP	group OECdl	22315
@NP	3	22330
@NP	4 months	22332
@NP	axonal regeneration and functional spinal reconnection	22353
@NP	Figs. 1C	22409
@NP	D ; Table 1	22418
@NP	D	22418
@NP	Table 1	22421
@NP	The proportions of rats that recovered MEPs	22431
@NP	The proportions	22431
@NP	rats that recovered MEPs	22450
@NP	rats	22450
@NP	MEPs	22470
@NP	OECac and OECdl groups	22516
@NP	both	22544
@NP	P < 0.05 , chi-square test	22563
@NP	P	22563
@NP	< 0.05 , chi-square test	22565
@NP	<	22565
@NP	0.05 , chi-square test	22567
@NP	0.05	22567
@NP	chi-square test	22573
@NP	DM groups	22598
@NP	intact animals	22621
@NP	the first MEPs recorded in regenerated animals	22637
@NP	the first MEPs	22637
@NP	regenerated animals	22664
@NP	multiple waves of low amplitude and long latency	22697
@NP	multiple waves	22697
@NP	low amplitude and long latency	22715
@NP	low amplitude	22715
@NP	long latency	22733
@NP	time	22753
@NP	MEPs	22759
@NP	amplitude	22777
@NP	latency	22801
@NP	single or polyphasic waves -LRB- Figs. 1E -- F -RRB-	22828
@NP	single or polyphasic waves	22828
@NP	Figs. 1E -- F	22856
@NP	Figs. 1E	22856
@NP	F	22865
@NP	animals that received an acute OEC graft	22884
@NP	animals	22884
@NP	an acute OEC graft	22906
@NP	MEPs of higher amplitude and shorter latency	22940
@NP	MEPs	22940
@NP	higher amplitude and shorter latency	22948
@NP	higher amplitude	22948
@NP	shorter latency	22969
@NP	those with a delayed transplant -LRB- Figs. 1G -- H -RRB-	22990
@NP	those	22990
@NP	a delayed transplant -LRB- Figs. 1G -- H -RRB-	23001
@NP	a delayed transplant	23001
@NP	Figs. 1G -- H	23023
@NP	Figs. 1G	23023
@NP	H	23032
@NP	9 months	23039
@NP	the mean amplitude of MEPs	23049
@NP	the mean amplitude	23049
@NP	MEPs	23071
@NP	0.72 ± 0.41 mV in group OECac -LRB- n = 4 -RRB- and 0.28 ± 0.11 mV	23080
@NP	0.72 ± 0.41 mV in group OECac -LRB- n = 4 -RRB-	23080
@NP	0.72 ±	23080
@NP	group OECac -LRB- n = 4 -RRB-	23098
@NP	group OECac	23098
@NP	n	23111
@NP	4	23115
@NP	0.28 ± 0.11 mV	23122
@NP	0.28 ±	23122
@NP	0.11 mV	23129
@NP	group OECdl -LRB- n = 4 -RRB- -LRB- Table 1 -RRB-	23140
@NP	group OECdl -LRB- n = 4 -RRB-	23140
@NP	group OECdl	23140
@NP	n	23153
@NP	4	23157
@NP	Table 1	23161
@NP	the mean latency	23179
@NP	16.0 ± 2.1 ms and 17.6 ± 1.2 ms	23200
@NP	16.0 ± 2.1 ms	23200
@NP	16.0 ±	23200
@NP	2.1 ms	23207
@NP	17.6 ± 1.2 ms	23218
@NP	17.6 ±	23218
@NP	1.2 ms	23225
@NP	injury	23254
@NP	the amplitude of the M-wave in plantar muscles	23262
@NP	the amplitude	23262
@NP	the M-wave in plantar muscles	23279
@NP	the M-wave	23279
@NP	plantar muscles	23293
@NP	7 -- 9 mV	23319
@NP	7	23319
@NP	9 mV	23321
@NP	the H-wave	23338
@NP	250 -- 600 AV	23349
@NP	250	23349
@NP	600 AV	23353
@NP	injury	23367
@NP	the M-wave amplitude	23375
@NP	80 -- 90 % of preoperative values	23420
@NP	80	23420
@NP	90 % of preoperative values	23423
@NP	90 %	23423
@NP	preoperative values	23430
@NP	the amplitude of the H-wave	23459
@NP	the amplitude	23459
@NP	the H-wave	23476
@NP	all injured rats -LRB- Table 1 -RRB-	23500
@NP	all	23500
@NP	rats -LRB- Table 1 -RRB-	23512
@NP	rats	23512
@NP	Table 1	23518
@NP	The H/M ratio	23528
@NP	the 9-month follow-up in DM-injected animals	23573
@NP	the 9-month follow-up	23573
@NP	DM-injected animals	23598
@NP	OEC-transplanted animals	23630
@NP	the H/M ratio	23655
@NP	the first 3	23686
@NP	4 months	23698
@NP	Figs. 2A , B	23739
@NP	Figs. 2A	23739
@NP	B	23748
@NP	The facilitation of the H-reflex	23752
@NP	The facilitation	23752
@NP	the H-reflex	23772
@NP	group OECac	23814
@NP	all the follow-up	23833
@NP	9 months	23855
@NP	the H/M ratio	23865
@NP	717 ± 94 % , 679 ± 100 % , 335 ± 70 % , and 420 ± 50 % with respect	23888
@NP	717 ± 94 %	23888
@NP	717 ±	23888
@NP	94 %	23894
@NP	679 ± 100 %	23899
@NP	679 ±	23899
@NP	335 ± 70 %	23911
@NP	335 ±	23911
@NP	70 %	23917
@NP	420 ± 50 % with respect	23926
@NP	420 ±	23926
@NP	respect	23941
@NP	preoperative values in DMac , DMdl , OECac , and OECdl groups , respectively	23952
@NP	preoperative values in DMac , DMdl , OECac , and OECdl groups	23952
@NP	preoperative values	23952
@NP	DMac , DMdl , OECac , and OECdl groups	23975
@NP	Figs. 2A , B	24026
@NP	Figs. 2A	24026
@NP	B	24035
@NP	OEC-transplanted rats in comparison	24068
@NP	OEC-transplanted rats	24068
@NP	comparison	24093
@NP	DM-injected rats	24109
@NP	Neurological outcome	24127
@NP	injury	24155
@NP	all the animals	24163
@NP	normal locomotor activity	24186
@NP	21	24222
@NP	the BBB scale	24228
@NP	7 days	24246
@NP	there	24265
@NP	complete absence of hindlimb movements in all the rats -LRB- Fig. 2C -RRB-	24275
@NP	complete absence	24275
@NP	hindlimb movements in all the rats -LRB- Fig. 2C -RRB-	24295
@NP	hindlimb movements	24295
@NP	all the rats -LRB- Fig. 2C -RRB-	24317
@NP	all the rats	24317
@NP	Fig. 2C	24331
@NP	follow-up	24348
@NP	rats of DMac and DMdl groups	24359
@NP	rats	24359
@NP	DMac and DMdl groups	24367
@NP	no hindlimb movement -LRB- score 0 -RRB-	24402
@NP	no hindlimb movement	24402
@NP	score 0	24424
@NP	slight movements of one or two joints	24434
@NP	slight movements	24434
@NP	one or two joints	24454
@NP	extensive movement of one joint -LRB- scores 1 or 2 -RRB-	24476
@NP	extensive movement of one joint	24476
@NP	extensive movement	24476
@NP	one joint	24498
@NP	scores 1 or 2	24509
@NP	contrast	24528
@NP	acutely OEC-transplanted animals	24538
@NP	hindlimb motor skills	24595
@NP	2 to 3 months	24622
@NP	the end of the study	24639
@NP	the end	24639
@NP	the study	24650
@NP	a final average BBB score of 4.2 ± 0.7 points	24670
@NP	a final average BBB score	24670
@NP	4.2 ± 0.7 points	24699
@NP	4.2 ±	24699
@NP	0.7 points	24705
@NP	Rats with delayed OEC grafts	24717
@NP	Rats	24717
@NP	delayed OEC grafts	24727
@NP	hindlimb movements	24756
@NP	3 to 4 months	24780
@NP	a final average score of 3.7 ± 0.4 points -LRB- Fig. 2C -RRB-	24804
@NP	a final average score	24804
@NP	3.7 ± 0.4 points -LRB- Fig. 2C -RRB-	24829
@NP	3.7 ± 0.4 points	24829
@NP	Fig. 2C	24847
@NP	OEC-transplanted rats that did not show MEPs recovery	24857
@NP	OEC-transplanted rats	24857
@NP	MEPs recovery	24897
@NP	BBB values similar to those of DM-injected animals	24915
@NP	BBB values	24915
@NP	those of DM-injected animals	24937
@NP	those	24937
@NP	DM-injected animals	24946
@NP	OEC-transplanted rats that recovered MEPs	24975
@NP	OEC-transplanted rats	24975
@NP	MEPs	25012
@NP	higher values	25024
@NP	between 4 and 7 points	25046
@NP	average 5.3	25070
@NP	± 0.5	25082
@NP	the 4 rats of group OECac , and 4.1 ± 0.3 for the 4 rats of group OECdl	25092
@NP	the 4 rats of group OECac	25092
@NP	the 4 rats	25092
@NP	group OECac	25106
@NP	4.1 ± 0.3 for the 4 rats of group OECdl	25123
@NP	4.1 ± 0.3	25123
@NP	the 4 rats of group OECdl	25137
@NP	the 4 rats	25137
@NP	group OECdl	25151
@NP	Fig. 2D	25165
@NP	The BBB score	25175
@NP	the amplitude -LRB- r = 0.81 , P < 0.001 -RRB-	25223
@NP	the amplitude	25223
@NP	r = 0.81 , P < 0.001	25238
@NP	r	25238
@NP	= 0.81 , P < 0.001	25240
@NP	= 0.81 , P <	25240
@NP	0.81 , P	25242
@NP	0.81	25242
@NP	P	25248
@NP	0.001	25252
@NP	the latency of MEPs -LRB- r = -0.44 , P < 0.05 -RRB-	25268
@NP	the latency	25268
@NP	MEPs -LRB- r = -0.44 , P < 0.05 -RRB-	25283
@NP	MEPs	25283
@NP	r = -0.44 , P < 0.05	25289
@NP	r	25289
@NP	= -0.44 , P < 0.05	25291
@NP	= -0.44 , P <	25291
@NP	-0.44 , P	25293
@NP	-0.44	25293
@NP	P	25300
@NP	0.05	25304
@NP	the climbing test	25314
@NP	all animals	25333
@NP	the highest angle -LRB- 90 ° -RRB-	25363
@NP	the highest angle	25363
@NP	90 °	25382
@NP	injury	25394
@NP	One week following spinal cord transection , none of the rats	25402
@NP	One week	25402
@NP	spinal cord transection , none of the rats	25421
@NP	spinal cord transection	25421
@NP	none of the rats	25446
@NP	none	25446
@NP	the rats	25454
@NP	the lowest inclination angle -LRB- 45 ° -RRB-	25472
@NP	the lowest inclination angle	25472
@NP	45 °	25502
@NP	1 month to the end of the follow-up	25513
@NP	1 month	25513
@NP	the end of the follow-up	25524
@NP	the end	25524
@NP	the follow-up	25535
@NP	all the rats	25550
@NP	the platform	25572
@NP	inclinations of 45 ° and 60 °	25590
@NP	inclinations	25590
@NP	45 ° and 60 °	25606
@NP	45 °	25606
@NP	60 °	25614
@NP	some animals from all the experimental groups	25623
@NP	some animals	25623
@NP	all the experimental groups	25641
@NP	the inclined grid at 90 ° angle	25687
@NP	the inclined grid	25687
@NP	90 ° angle	25708
@NP	animals that achieved the maximal level	25734
@NP	animals	25734
@NP	the maximal level	25756
@NP	the same	25783
@NP	the different monthly tests	25795
@NP	Axonal regeneration	25824
@NP	final dissection	25851
@NP	the transection site	25869
@NP	the presence of an opaque tissue binding rostral and caudal stumps	25908
@NP	the presence	25908
@NP	an opaque tissue binding rostral and caudal stumps	25924
@NP	an opaque tissue binding rostral	25924
@NP	caudal stumps	25961
@NP	animals of DM groups -LRB- Figs. 3A -- B -RRB-	25978
@NP	animals	25978
@NP	DM groups -LRB- Figs. 3A -- B -RRB-	25989
@NP	DM groups	25989
@NP	Figs. 3A -- B	26000
@NP	Figs. 3A	26000
@NP	B	26009
@NP	contrast	26016
@NP	animals of OEC groups	26029
@NP	animals	26029
@NP	OEC groups	26040
@NP	the transection site	26052
@NP	the presence	26080
@NP	a white tissue that bridged both cord stumps -LRB- Figs. 3C -- D -RRB-	26096
@NP	a white tissue	26096
@NP	both cord stumps	26124
@NP	Figs. 3C -- D	26142
@NP	Figs. 3C	26142
@NP	D	26151
@NP	the scar tissue	26172
@NP	meningeal origin	26209
@NP	the two stumps	26258
@NP	reactive gliosis and cavitation	26279
@NP	reactive gliosis	26279
@NP	cavitation	26300
@NP	Fig. 4A	26327
@NP	9 months postinjury	26340
@NP	DM-injected animals	26364
@NP	many NF-200 - and GAP-43-immunoreactive axons	26385
@NP	many NF-200	26385
@NP	GAP-43-immunoreactive axons	26402
@NP	the cranial and caudal stumps	26444
@NP	considerably less labeled profiles	26479
@NP	the central scar	26531
@NP	most of them	26552
@NP	most	26552
@NP	them	26560
@NP	the scar interface -LRB- Fig. 4B -RRB-	26576
@NP	the scar interface	26576
@NP	Fig. 4B	26596
@NP	contrast	26609
@NP	OEC-transplanted animals	26622
@NP	NF200 and GAP-43 labeled axons	26648
@NP	NF200 and GAP-43	26648
@NP	axons	26673
@NP	the lesion site	26703
@NP	group OECac -LRB- Figs. 4C -- D -RRB-	26743
@NP	group OECac	26743
@NP	Figs. 4C -- D	26756
@NP	Figs. 4C	26756
@NP	D	26765
@NP	Sensory fibers , identified by immunolabeling against CGRP ,	26769
@NP	Sensory fibers	26769
@NP	immunolabeling against CGRP	26799
@NP	immunolabeling	26799
@NP	CGRP	26822
@NP	the dorsal aspect of the caudal stump in all experimental groups	26844
@NP	the dorsal aspect	26844
@NP	the caudal stump in all experimental groups	26865
@NP	the caudal stump	26865
@NP	all experimental groups	26885
@NP	the degree of immunoreactivity	26919
@NP	the degree	26919
@NP	immunoreactivity	26933
@NP	groups OECac and OECdl	26978
@NP	comparison with groups DMac and DMdl -LRB- P < 0.01 -RRB- -LRB- Fig. 4E -RRB-	27004
@NP	comparison	27004
@NP	groups DMac and DMdl -LRB- P < 0.01 -RRB- -LRB- Fig. 4E -RRB-	27020
@NP	groups DMac and DMdl -LRB- P < 0.01 -RRB-	27020
@NP	groups DMac and DMdl	27020
@NP	P < 0.01	27043
@NP	P	27043
@NP	< 0.01	27045
@NP	<	27045
@NP	0.01	27047
@NP	Fig. 4E	27054
@NP	Some CGRP-positive axons	27064
@NP	the epicenter of the lesion	27097
@NP	the epicenter	27097
@NP	the lesion	27114
@NP	they	27131
@NP	a dorsoventral orientation	27144
@NP	a few of them	27176
@NP	a few	27176
@NP	them	27185
@NP	the cranial stump -LRB- Fig. 4F -RRB-	27198
@NP	the cranial stump	27198
@NP	Fig. 4F	27217
@NP	Significantly higher immunoreactivity for CGRP	27227
@NP	Significantly higher immunoreactivity	27227
@NP	CGRP	27269
@NP	the epicenter region	27291
@NP	the cranial stump in group OECac	27319
@NP	the cranial stump	27319
@NP	group OECac	27340
@NP	the other three groups -LRB- P < 0.001 -RRB- -LRB- Fig. 4E -RRB-	27360
@NP	the other three groups -LRB- P < 0.001 -RRB-	27360
@NP	the other three groups	27360
@NP	P < 0.001	27385
@NP	P	27385
@NP	< 0.001	27387
@NP	<	27387
@NP	0.001	27389
@NP	Fig. 4E	27397
@NP	regenerated descending motor axons , the corticospinal tract	27419
@NP	regenerated descending motor axons	27419
@NP	the corticospinal tract	27455
@NP	BDA	27509
@NP	immunohistochemistry	27610
@NP	serotonin and DhOH	27635
@NP	the cranial stump	27672
@NP	corticospinal axons	27691
@NP	the dorsal columns and fewer axons	27739
@NP	the dorsal columns	27739
@NP	fewer axons	27762
@NP	the ventral funiculi	27777
@NP	Raphespinal and coerulospinal axons	27799
@NP	ventral and ventrolateral aspects of the spinal cord	27859
@NP	ventral and ventrolateral aspects	27859
@NP	the spinal cord	27896
@NP	all transected animals	27916
@NP	these fibers	27940
@NP	the epicenter region	27979
@NP	they	28007
@NP	orientation and spread	28023
@NP	outermost part of the spinal cord -LRB- Figs. 5B -- C -RRB-	28082
@NP	outermost part	28082
@NP	the spinal cord -LRB- Figs. 5B -- C -RRB-	28100
@NP	the spinal cord	28100
@NP	Figs. 5B -- C	28117
@NP	Figs. 5B	28117
@NP	C	28126
@NP	more labeled fibers	28145
@NP	the rostral	28181
@NP	epicenter sites in OEC	28197
@NP	epicenter sites	28197
@NP	OEC	28216
@NP	DMinjected animals -LRB- Fig. 5A -RRB-	28229
@NP	DMinjected animals	28229
@NP	Fig. 5A	28249
@NP	No descending fibers	28259
@NP	the caudal glial scar	28288
@NP	DM-injected animals	28313
@NP	one rat of group DMac	28352
@NP	one rat	28352
@NP	group DMac	28363
@NP	some scattered raphespinal and corticospinal axons	28375
@NP	some scattered raphespinal	28375
@NP	corticospinal axons	28406
@NP	1 mm	28443
@NP	the rostral edge of the caudal stump	28453
@NP	the rostral edge	28453
@NP	the caudal stump	28473
@NP	contrast	28494
@NP	long axonal regeneration	28504
@NP	animals	28550
@NP	an OEC transplant	28568
@NP	corticospinal , raphespinal , and coerulospinal fibers	28592
@NP	lumbar segments of the spinal cord	28659
@NP	lumbar segments	28659
@NP	the spinal cord	28678
@NP	Descending fibers	28695
@NP	the caudal stump	28732
@NP	the gray matter	28770
@NP	the white matter -LRB- Figs. 5E -- J -RRB-	28798
@NP	the white matter	28798
@NP	Figs. 5E -- J	28816
@NP	Figs. 5E	28816
@NP	J	28825
@NP	the cord lumbar segments	28832
@NP	regenerated fibers	28858
@NP	the central gray matter -LRB- laminae X and VIII -RRB-	28898
@NP	the central gray matter	28898
@NP	laminae X and VIII	28923
@NP	laminae X	28923
@NP	VIII	28937
@NP	a few axons	28948
@NP	the ventral gray matter	28987
@NP	motoneurons -LRB- Figs. 6A -- C -RRB-	29033
@NP	motoneurons	29033
@NP	Figs. 6A -- C	29046
@NP	Figs. 6A	29046
@NP	C	29055
@NP	Significant correlations	29059
@NP	BBB score	29103
@NP	density of serotoninergic , noradrenergic and corticospinal fibers	29117
@NP	density	29117
@NP	serotoninergic , noradrenergic and corticospinal fibers	29128
@NP	the lesion edge	29193
@NP	r = 0.93 , r = 0.95 , r = 0.87 , respectively , all P < 0.001	29210
@NP	r	29210
@NP	0.93 , r = 0.95 , r = 0.87 , respectively , all P < 0.001	29214
@NP	0.93 , r = 0.95 , r = 0.87 , respectively	29214
@NP	0.93	29214
@NP	r = 0.95	29220
@NP	r	29220
@NP	0.95	29224
@NP	r = 0.87 , respectively	29230
@NP	r	29230
@NP	= 0.87	29232
@NP	all P < 0.001	29254
@NP	all P	29254
@NP	0.001	29262
@NP	the amplitude	29281
@NP	MEPs and the density	29298
@NP	MEPs	29298
@NP	the density	29307
@NP	fibers	29322
@NP	r = 0.90 , r = 0.92 , r = 0.77 , respectively , all P < 0.001	29330
@NP	r	29330
@NP	0.90 , r = 0.92 , r = 0.77 , respectively , all P < 0.001	29334
@NP	0.90 , r = 0.92 , r = 0.77 , respectively	29334
@NP	0.90	29334
@NP	r = 0.92	29340
@NP	r	29340
@NP	r = 0.77 , respectively	29350
@NP	r	29350
@NP	= 0.77	29352
@NP	all P < 0.001	29374
@NP	all P	29374
@NP	0.001	29382
@NP	We	29390
@NP	transplanted OECs	29415
@NP	immunostaining against p75NTR	29439
@NP	immunostaining	29439
@NP	p75NTR	29462
@NP	previous studies	29476
@NP	Garcı ' a-Alı ' as et al. , 2004	29494
@NP	Garcı ' a-Alı	29494
@NP	et al.	29509
@NP	2004	29517
@NP	Plant et al. , 2003	29523
@NP	Plant	29523
@NP	et al. , 2003	29529
@NP	et al.	29529
@NP	2003	29537
@NP	Resnick et al. , 2003	29543
@NP	Resnick	29543
@NP	et al. , 2003	29551
@NP	et al.	29551
@NP	2003	29559
@NP	Ruitenberg et al. , 2003 ; Takami et al. ,	29565
@NP	Ruitenberg	29565
@NP	et al. , 2003 ; Takami et al. ,	29576
@NP	et al.	29576
@NP	2003 ; Takami et al.	29584
@NP	2003	29584
@NP	Takami et al.	29590
@NP	Takami	29590
@NP	et al.	29597
@NP	2002	29605
@NP	no p75NTR-immunoreactive cells	29616
@NP	the spinal cord parenchyma of any transplanted animal after 9 months	29668
@NP	the spinal cord parenchyma	29668
@NP	any transplanted animal after 9 months	29698
@NP	any transplanted animal	29698
@NP	9 months	29728
@NP	GFAP and NG2 expression GFAP and NG2 stainings	29738
@NP	GFAP and NG2 expression GFAP	29738
@NP	NG2 stainings	29771
@NP	the nonpermissive environment for regeneration	29807
@NP	the nonpermissive environment	29807
@NP	regeneration	29841
@NP	spinal cord transection	29860
@NP	NG2 immunostaining	29885
@NP	meningeallike cells	29927
@NP	a transverse orientation	29961
@NP	the lesion epicenter	29993
@NP	Fig. 6D	30015
@NP	Double staining against NG2 and GAP-43	30025
@NP	Double staining	30025
@NP	NG2 and GAP-43	30049
@NP	regenerating axons	30078
@NP	the NG2 barrier	30111
@NP	their original pathway	30139
@NP	NG2-immunoreactive cells -LRB- Figs. 6D -- F -RRB-	30172
@NP	NG2-immunoreactive cells	30172
@NP	Figs. 6D -- F	30198
@NP	Figs. 6D	30198
@NP	F	30207
@NP	NG2-positive cells with stellate morphology and non-immunoreactive for GFAP	30211
@NP	NG2-positive cells with stellate morphology	30211
@NP	NG2-positive cells	30211
@NP	stellate morphology	30235
@NP	non-immunoreactive for GFAP	30259
@NP	non-immunoreactive	30259
@NP	GFAP	30282
@NP	the lesion margins	30304
@NP	the spinal cord parenchyma	30339
@NP	acute OEC grafts	30383
@NP	decreased NG2 immunoreactivity	30412
@NP	comparison	30446
@NP	DM-injected animals within the lesion epicenter	30462
@NP	DM-injected animals	30462
@NP	the lesion epicenter	30489
@NP	cranial and caudal stumps -LRB- Fig. 7A -RRB-	30517
@NP	cranial and caudal stumps	30517
@NP	Fig. 7A	30544
@NP	Delayed OEC grafts	30554
@NP	NG2 immunoreactivity	30590
@NP	The glial scar , surrounding the lesion epicenter ,	30637
@NP	The glial scar	30637
@NP	the lesion epicenter	30665
@NP	numerous hypertrophic interwoven GFAP-positive processes	30697
@NP	The density of GFAP-immunoreactive processes	30755
@NP	The density	30755
@NP	GFAP-immunoreactive processes	30770
@NP	the lesion margins	30822
@NP	the adjacent cord tissue	30848
@NP	the lesion site	30908
@NP	Astrocytes in samples of OECac rats	30925
@NP	Astrocytes	30925
@NP	samples of OECac rats	30939
@NP	samples	30939
@NP	OECac rats	30950
@NP	less hypertrophied morphology and thinner processes	30965
@NP	less hypertrophied morphology	30965
@NP	thinner processes	30999
@NP	a more aligned meshwork	31029
@NP	DM-injected animals	31070
@NP	Figs. 7C -- F	31091
@NP	Figs. 7C	31091
@NP	F	31100
@NP	group OECac	31120
@NP	signifi	31136
@NP	GFAP expression	31160
@NP	both cranial and caudal cord regions with respect	31179
@NP	both cranial and caudal cord regions	31179
@NP	respect	31221
@NP	both DM-injected groups	31232
@NP	group OECdl	31265
@NP	intermediate values -LRB- Fig. 7B -RRB-	31281
@NP	intermediate values	31281
@NP	Fig. 7B	31302
@NP	Discussion	31313
@NP	The results of the present work	31324
@NP	The results	31324
@NP	the present work	31339
@NP	both	31373
@NP	OEC transplantation	31396
@NP	the	31421
@NP	spinal cord of adult rats	31447
@NP	spinal cord	31447
@NP	adult rats	31462
@NP	long axonal regeneration and partial recovery of motor functions	31481
@NP	long axonal regeneration	31481
@NP	partial recovery of motor functions	31510
@NP	partial recovery	31510
@NP	motor functions	31530
@NP	spinal cord transection	31553
@NP	only rats that received an OEC transplant	31578
@NP	only rats	31578
@NP	an OEC transplant	31602
@NP	recovery of MEPs	31627
@NP	recovery	31627
@NP	MEPs	31639
@NP	no electrophysiological responses	31653
@NP	nontransplanted rats over the 9 months follow-up	31704
@NP	nontransplanted rats	31704
@NP	the 9 months follow-up	31730
@NP	parallel with MEP restitution	31757
@NP	parallel	31757
@NP	MEP restitution	31771
@NP	transplanted animals	31788
@NP	slight improvement of hindlimb motor function	31816
@NP	slight improvement	31816
@NP	hindlimb motor function	31838
@NP	significant reduction of lumbar Hreflex facilitation	31866
@NP	significant reduction	31866
@NP	lumbar Hreflex facilitation	31891
@NP	The histological results	31920
@NP	long axonal regeneration	31952
@NP	corticospinal , raphespinal , and coerulospinal descending fibers	31980
@NP	possible reconnection with lumbar motor nuclei	32048
@NP	possible reconnection	32048
@NP	lumbar motor nuclei	32075
@NP	OEC transplanted rats	32103
@NP	higher immunoreactivity levels	32136
@NP	NF-200 , GAP-43 , and CGRP , and lower for GFAP and NG2 immunoreactivity	32171
@NP	NF-200 , GAP-43 , and CGRP ,	32171
@NP	lower for GFAP and NG2 immunoreactivity	32201
@NP	lower	32201
@NP	GFAP and NG2 immunoreactivity	32211
@NP	OEC	32254
@NP	DMinjected animals	32267
@NP	neurological , electrophysiological , and histological results	32296
@NP	rats	32381
@NP	an acute OEC transplant	32400
@NP	those with 1 week delayed transplant	32432
@NP	those	32432
@NP	1 week delayed transplant	32443
@NP	1 week	32443
@NP	transplant	32458
@NP	A key point	32959
@NP	treatments to repair the injured spinal cord	32977
@NP	the injured spinal cord	32998
@NP	functional recovery	33033
@NP	axonal pathways	33063
@NP	the lesion	33102
@NP	changes in spinal circuits	33119
@NP	changes	33119
@NP	spinal circuits	33130
@NP	the lesion -LRB- Fouad and Pearson , 2004 -RRB-	33156
@NP	the lesion	33156
@NP	Fouad and Pearson , 2004	33168
@NP	Fouad	33168
@NP	Pearson , 2004	33178
@NP	Pearson	33178
@NP	2004	33187
@NP	rats with OEC transplants	33197
@NP	rats	33197
@NP	OEC transplants	33207
@NP	we	33224
@NP	descending fibers from motor cortex and brainstem	33238
@NP	descending fibers	33238
@NP	motor cortex and brainstem	33261
@NP	the lesion	33301
@NP	lumbar segments	33341
@NP	A novel finding of the present work	33358
@NP	A novel finding	33358
@NP	the present work	33377
@NP	spinal cord transection	33408
@NP	70 -- 80 % of OEC-transplanted rats	33433
@NP	70 -- 80 %	33433
@NP	70	33433
@NP	OEC-transplanted rats	33443
@NP	recovery of MEPs , but none of the control DM-injected rats	33472
@NP	recovery of MEPs	33472
@NP	recovery	33472
@NP	MEPs	33484
@NP	none of the control DM-injected rats	33494
@NP	none	33494
@NP	the control DM-injected rats	33502
@NP	MEPs	33532
@NP	electrical stimulation	33552
@NP	cortical and brainstem motor neurons	33578
@NP	impulses along the spinal cord	33632
@NP	impulses	33632
@NP	the spinal cord	33647
@NP	lumbar motoneurons -LRB- Konrad and Tacker , 1990 -RRB-	33673
@NP	lumbar motoneurons	33673
@NP	Konrad and Tacker	33693
@NP	1990	33712
@NP	spinal cord transection	33725
@NP	MEPs	33750
@NP	all descending tracts	33773
@NP	they	33814
@NP	time	33838
@NP	spontaneous axonal regeneration	33851
@NP	the non-transplanted spinal cord -LRB- Valero-Cabre ' et al. , 2004 -RRB-	33896
@NP	the non-transplanted spinal cord	33896
@NP	Valero-Cabre ' et al. , 2004	33930
@NP	Valero-Cabre '	33930
@NP	et al.	33944
@NP	2004	33952
@NP	recovery of electrophysiological responses observed after OEC transplantation	33970
@NP	recovery	33970
@NP	electrophysiological responses observed after OEC transplantation	33982
@NP	electrophysiological responses	33982
@NP	OEC transplantation	34028
@NP	regrowth	34067
@NP	caudal functional reconnection	34080
@NP	a number of supraspinal axons	34114
@NP	a number	34114
@NP	supraspinal axons	34126
@NP	the lesion site	34157
@NP	OEC-grafted animals	34174
@NP	their locomotor behavior	34203
@NP	MEPs	34238
@NP	recovery of motor skills	34271
@NP	recovery	34271
@NP	motor skills	34283
@NP	descending control of hindlimb movements	34317
@NP	descending control	34317
@NP	hindlimb movements	34339
@NP	Ramo ' n-Cueto et al. -LRB- 2000 -RRB-	34359
@NP	Ramo ' n-Cueto et al.	34359
@NP	Ramo ' n-Cueto	34359
@NP	Ramo '	34359
@NP	et al.	34372
@NP	2000	34380
@NP	recovery of hindlimb function	34395
@NP	recovery	34395
@NP	hindlimb function	34407
@NP	test	34441
@NP	acute OEC transplantation	34449
@NP	complete spinal cord	34481
@NP	the results	34524
@NP	the present and other studies	34545
@NP	Casas	34576
@NP	et al. , 2001 ; Valero-Cabre ' and Navarro , unpublished data	34582
@NP	et al.	34582
@NP	2001 ; Valero-Cabre ' and Navarro	34590
@NP	2001	34590
@NP	Valero-Cabre ' and Navarro	34596
@NP	Valero-Cabre '	34596
@NP	Navarro	34614
@NP	unpublished data	34623
@NP	the climbing test	34655
@NP	some control-transected animals	34699
@NP	high scores , probably due to reflex rather than voluntary hindlimb movements	34740
@NP	high scores	34740
@NP	reflex rather than voluntary hindlimb movements	34769
@NP	reflex	34769
@NP	voluntary hindlimb movements	34788
@NP	contrast	34821
@NP	the improvement in the BBB score observed in OEC-transplanted animals	34831
@NP	the improvement	34831
@NP	the BBB score observed in OEC-transplanted animals	34850
@NP	the BBB score	34850
@NP	OEC-transplanted animals	34876
@NP	voluntary	34919
@NP	spinal reflex activity for at least four reasons	34944
@NP	spinal reflex activity	34944
@NP	at least four reasons	34971
@NP	recovery of locomotor function	35010
@NP	recovery	35010
@NP	locomotor function	35022
@NP	OEC-transplanted animals in which MEPs were restituted	35062
@NP	OEC-transplanted animals	35062
@NP	MEPs	35096
@NP	the significant correlation	35126
@NP	BBB score	35168
@NP	MEP amplitude and latency	35182
@NP	MEP amplitude	35182
@NP	latency	35200
@NP	animals with better motors skills	35223
@NP	animals	35223
@NP	better motors skills	35236
@NP	higher reconnection and faster central conduction	35272
@NP	higher reconnection	35272
@NP	faster central conduction	35296
@NP	Third	35323
@NP	significant correlations	35330
@NP	motor recovery and density of descending motor axons	35374
@NP	motor recovery and density	35374
@NP	descending motor axons	35404
@NP	the lesion	35449
@NP	animals with OEC grafts	35469
@NP	animals	35469
@NP	OEC grafts	35482
@NP	reduced hyperreflexia	35503
@NP	control-transected animals	35537
@NP	the H/M amplitude ratio	35577
@NP	The H/M amplitude ratio	35602
@NP	spinal cord section -LRB- Malmsten , 1983 ; Valero-Cabre ' et al. , 2004 -RRB-	35642
@NP	spinal cord section	35642
@NP	Malmsten , 1983 ; Valero-Cabre ' et al. , 2004	35663
@NP	Malmsten	35663
@NP	1983 ; Valero-Cabre ' et al.	35673
@NP	1983	35673
@NP	Valero-Cabre ' et al.	35679
@NP	Valero-Cabre '	35679
@NP	et al.	35693
@NP	2004	35701
@NP	the H-reflex	35715
@NP	interruption of supraspinal motor control	35751
@NP	interruption	35751
@NP	supraspinal motor control	35767
@NP	The increase in the H/M ratio	35794
@NP	The increase	35794
@NP	the H/M ratio	35810
@NP	time in DMinjected groups along the 9 months	35845
@NP	time	35845
@NP	DMinjected groups along the 9 months	35853
@NP	DMinjected groups	35853
@NP	the 9 months	35877
@NP	injury	35896
@NP	the other hand	35907
@NP	the H/M ratio	35923
@NP	2 to 3 months	35958
@NP	3 to 4 months in delayed OEC-grafted animals	35992
@NP	3 to 4 months	35992
@NP	delayed OEC-grafted animals	36009
@NP	the time points corresponding with MEPs recovery	36038
@NP	the time points	36038
@NP	MEPs recovery	36073
@NP	These results	36088
@NP	regenerated supraspinal axons in OEC-transplanted animals	36115
@NP	regenerated supraspinal axons	36115
@NP	OEC-transplanted animals	36148
@NP	the previously facilitated reflex circuits at lumbar cord segments	36182
@NP	the previously	36182
@NP	reflex circuits	36209
@NP	lumbar cord segments	36228
@NP	acute but not delayed OEC grafts	36265
@NP	acute	36265
@NP	not delayed OEC grafts	36275
@NP	a reduction	36306
@NP	the H/M ratio	36321
@NP	rats in which MEPs did not recover	36343
@NP	rats	36343
@NP	MEPs	36357
@NP	The neuroprotective effects	36379
@NP	transplanted cells at perilesional regions after acute transplantation	36418
@NP	transplanted cells	36418
@NP	perilesional regions after acute transplantation	36440
@NP	perilesional regions	36440
@NP	acute transplantation	36467
@NP	this fact -LRB- Verdu ' et al. , 2001	36503
@NP	this fact -LRB- Verdu ' et al.	36503
@NP	this fact	36503
@NP	Verdu ' et al.	36514
@NP	Verdu '	36514
@NP	et al.	36521
@NP	2001	36529
@NP	These results	36536
@NP	return of electrophysiological and behavioral responses after OEC transplants	36563
@NP	return	36563
@NP	electrophysiological and behavioral responses after OEC transplants	36573
@NP	electrophysiological and behavioral responses	36573
@NP	OEC transplants	36625
@NP	remnant fibers	36652
@NP	surgical transection	36677
@NP	motor improvement	36707
@NP	a extended period	36749
@NP	2 and 3 months following injury in OECac and OECdl groups , respectively	36768
@NP	2 and 3 months	36768
@NP	injury in OECac and OECdl groups , respectively	36793
@NP	injury in OECac and OECdl groups	36793
@NP	injury	36793
@NP	OECac and OECdl groups	36803
@NP	the reported time	36854
@NP	spontaneous recovery -LRB- Basso et al. , 1996 ; You et al. , 2003 -RRB-	36885
@NP	spontaneous recovery	36885
@NP	Basso	36907
@NP	et al. , 1996 ; You et al. , 2003	36913
@NP	et al.	36913
@NP	1996 ; You et al.	36921
@NP	1996	36921
@NP	You et al.	36927
@NP	You	36927
@NP	et al.	36931
@NP	2003	36939
@NP	Axonal regrowth and reconnection of descending motor fibers	36946
@NP	Axonal regrowth and reconnection	36946
@NP	descending motor fibers	36982
@NP	histological results	37023
@NP	Immunostaining against NF-200 and GAP-43	37045
@NP	Immunostaining	37045
@NP	NF-200 and GAP-43	37068
@NP	OEC-transplanted animals	37098
@NP	higher immunoreactivity	37133
@NP	the lesion epicenter	37164
@NP	DM-injected animals	37201
@NP	more axonal fibers	37238
@NP	transplanted animals	37280
@NP	DM groups , in OEC-grafted animals	37316
@NP	DM groups	37316
@NP	OEC-grafted animals	37330
@NP	more CGRP labeled sensory fibers	37351
@NP	more CGRP	37351
@NP	sensory fibers	37369
@NP	the lesion	37404
@NP	increased sprouting	37430
@NP	fibers , and also rostral	37463
@NP	fibers	37463
@NP	rostral	37480
@NP	the lesion edge	37491
@NP	regeneration of sensory fibers	37524
@NP	regeneration	37524
@NP	sensory fibers	37540
@NP	transplanted rats	37567
@NP	we	37595
@NP	some dorsal root afferent axons rostral to the lesion	37618
@NP	some dorsal root afferent axons rostral	37618
@NP	the lesion	37661
@NP	the lesion site	37691
@NP	axonal regeneration and continuity across the lesion site	37722
@NP	axonal regeneration and continuity	37722
@NP	the lesion site	37764
@NP	CGRP , DhOH , and serotonin containing axons	37796
@NP	CGRP , DhOH , and serotonin	37796
@NP	axons	37833
@NP	BDA-traced corticospinal axons	37855
@NP	raphespinal , and corticospinal fibers	37913
@NP	the caudal cord stump	37959
@NP	the lumbar segments of the spinal cord	37996
@NP	the lumbar segments	37996
@NP	the spinal cord	38019
@NP	they	38042
@NP	premotoneuronal pools	38062
@NP	ventral horn motoneurons	38098
@NP	OEC transplanted rats	38132
@NP	The presence of these descending regenerated fibers	38155
@NP	The presence	38155
@NP	these descending regenerated fibers	38171
@NP	the recovery of MEPs	38221
@NP	the recovery	38221
@NP	MEPs	38237
@NP	Other descending pathways	38243
@NP	rubrospinal , vestibulospinal , and reticulospinal tracts	38278
@NP	this work	38350
@NP	recovery of motor responses	38401
@NP	recovery	38401
@NP	motor responses	38413
@NP	MEPs	38439
@NP	amplitude	38457
@NP	their onset latency	38479
@NP	time	38505
@NP	9 months	38514
@NP	they	38523
@NP	3	38538
@NP	4 times longer latency and 10	38540
@NP	4 times	38540
@NP	latency	38555
@NP	10	38567
@NP	20 times lower amplitude in injured and transplanted rats	38570
@NP	20 times lower amplitude	38570
@NP	injured and transplanted rats	38598
@NP	injured	38598
@NP	transplanted rats	38610
@NP	intact animals	38636
@NP	This limited recovery of electrophysiological responses	38652
@NP	This limited recovery	38652
@NP	electrophysiological responses	38677
@NP	the relatively low improvement of walking behavior scored in the BBB scale	38725
@NP	the relatively low improvement	38725
@NP	behavior	38767
@NP	the BBB scale	38786
@NP	Timing of OEC transplant	38801
@NP	Timing	38801
@NP	OEC transplant	38811
@NP	respect to the time interval between injury and cell grafting	38831
@NP	respect	38831
@NP	the time interval between injury and cell grafting	38842
@NP	the time interval	38842
@NP	injury and cell grafting	38868
@NP	our results	38894
@NP	acute OEC transplants	38916
@NP	better functional and histological outcomes	38950
@NP	7-day delayed transplants	38999
@NP	differences	39035
@NP	most parameters	39072
@NP	Previous works	39089
@NP	diverging results	39118
@NP	the most suitable timing of glial cell grafting after spinal cord injury	39140
@NP	the most suitable timing	39140
@NP	glial cell grafting after spinal cord injury	39168
@NP	glial cell grafting	39168
@NP	spinal cord injury	39194
@NP	Martin et al. -LRB- 1996 -RRB-	39214
@NP	Martin et al.	39214
@NP	Martin	39214
@NP	et al.	39221
@NP	1996	39229
@NP	immediate -LRB- 30 min -RRB- or 10 - day	39253
@NP	immediate -LRB- 30 min -RRB-	39253
@NP	immediate	39253
@NP	30 min	39264
@NP	10 - day	39275
@NP	10	39275
@NP	day	39279
@NP	Schwann cell grafts	39291
@NP	not intermediate -LRB- 4 days -RRB- grafts	39316
@NP	4 days	39334
@NP	the size of cavitation	39357
@NP	the size	39357
@NP	cavitation	39369
@NP	mildly injured spinal cords	39383
@NP	They	39412
@NP	release of cytotoxic metabolites	39432
@NP	release	39432
@NP	cytotoxic metabolites	39443
@NP	acute transplantation	39487
@NP	the grafted cells at an intermediate stage -LRB- Martin et al. , 1996 -RRB-	39534
@NP	the grafted cells	39534
@NP	an intermediate stage -LRB- Martin et al. , 1996 -RRB-	39555
@NP	an intermediate stage	39555
@NP	Martin	39578
@NP	et al. , 1996	39585
@NP	et al.	39585
@NP	1996	39593
@NP	the other hand	39603
@NP	immediate transplantation of OECs	39619
@NP	immediate transplantation	39619
@NP	OECs	39648
@NP	locomotor behavior	39669
@NP	moderate contusion -LRB- Plant et al. , 2003 ; Resnick et al. , 2003 -RRB-	39694
@NP	moderate contusion	39694
@NP	Plant	39714
@NP	et al. , 2003 ; Resnick et al. , 2003	39720
@NP	et al.	39720
@NP	2003 ; Resnick et al.	39728
@NP	2003	39728
@NP	Resnick et al.	39734
@NP	Resnick	39734
@NP	et al.	39742
@NP	2003	39750
@NP	7-day delayed transplantation	39764
@NP	a slight improvement	39803
@NP	that	39833
@NP	tissue preservation	39839
@NP	timings	39881
@NP	Plant et al. , 2003	39890
@NP	Plant	39890
@NP	et al.	39896
@NP	2003	39904
@NP	The present study	39911
@NP	the regenerative effects exerted by OECs when they are transplanted acutely	39953
@NP	the regenerative effects	39953
@NP	OECs when they are transplanted acutely	39989
@NP	OECs	39989
@NP	they	39999
@NP	1 week delayed after spinal cord transection	40032
@NP	1 week	40032
@NP	spinal cord transection	40053
@NP	previous studies of complete spinal cord transection	40081
@NP	previous studies	40081
@NP	complete spinal cord transection	40101
@NP	OECs	40135
@NP	injury	40183
@NP	4 weeks	40201
@NP	most cases	40217
@NP	beneficial but limited effects	40228
@NP	axonal regeneration and recovery	40273
@NP	Lu et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000	40307
@NP	Lu	40307
@NP	et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000	40310
@NP	et al.	40310
@NP	2001	40318
@NP	2002 ; Ramo ' n-Cueto et al.	40324
@NP	2002	40324
@NP	Ramo ' n-Cueto et al.	40330
@NP	Ramo ' n-Cueto	40330
@NP	Ramo '	40330
@NP	et al.	40343
@NP	2000	40351
@NP	the effects of glial cell grafts	40369
@NP	the effects	40369
@NP	glial cell grafts	40384
@NP	the type and severity of the spinal cord injury	40424
@NP	the type and severity	40424
@NP	the spinal cord injury	40449
@NP	the time interval between injury and grafting	40473
@NP	the time interval	40473
@NP	injury and grafting	40499
@NP	the type and purity	40520
@NP	the	40543
@NP	cells for the transplant -LRB- Imaizumi et al. , 2000 -RRB-	40556
@NP	cells	40556
@NP	the transplant -LRB- Imaizumi et al. , 2000 -RRB-	40566
@NP	the transplant	40566
@NP	Imaizumi	40582
@NP	et al. , 2000	40591
@NP	et al.	40591
@NP	2000	40599
@NP	the amount of cells	40606
@NP	the amount	40606
@NP	cells	40620
@NP	the precise site of transplantation	40631
@NP	the precise site	40631
@NP	transplantation	40651
@NP	Mechanisms of OEC-induced regeneration	40668
@NP	Mechanisms	40668
@NP	OEC-induced regeneration	40682
@NP	previous studies on an incomplete spinal cord injury model	40710
@NP	previous studies	40710
@NP	an incomplete spinal cord injury model	40730
@NP	we	40770
@NP	OECs	40785
@NP	astrocyte hypertrophy	40801
@NP	chondroitin sulphate proteoglycan expression	40827
@NP	Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2001 , 2003	40873
@NP	Garcı ' a-Alı ' as et al.	40873
@NP	Garcı ' a-Alı	40873
@NP	et al.	40888
@NP	2004 ; Verdu ' et al.	40896
@NP	2004	40896
@NP	Verdu ' et al.	40902
@NP	Verdu '	40902
@NP	et al.	40909
@NP	2001 , 2003	40917
@NP	2001	40917
@NP	2003	40923
@NP	spinal cord transection	40936
@NP	GFAP and NG2 immunoreactivity	40961
@NP	9 months in animals with OEC transplants	41028
@NP	9 months	41028
@NP	animals with OEC transplants	41040
@NP	animals	41040
@NP	OEC transplants	41053
@NP	those grafted acutely	41084
@NP	those	41084
@NP	Reactive astrogliosis	41107
@NP	increased expression	41133
@NP	NG2 , the proteoglycan with highest axonal repelling features ,	41157
@NP	NG2	41157
@NP	the proteoglycan with highest axonal repelling features	41162
@NP	the proteoglycan	41162
@NP	highest axonal repelling features	41184
@NP	the failure	41233
@NP	axonal regeneration	41248
@NP	the central nervous system -LRB- Fawcett and Asher , 1999 -RRB-	41271
@NP	the central nervous system	41271
@NP	Fawcett and Asher	41299
@NP	1999	41318
@NP	GFAP and NG2 expressions	41325
@NP	the first week after spinal cord injury	41366
@NP	the first week	41366
@NP	spinal cord injury	41387
@NP	high levels	41420
@NP	at least 1 year -LRB- Camand et al. , 2004 ; Tang et al. , 2003 -RRB-	41436
@NP	at least 1 year	41436
@NP	Camand	41453
@NP	et al. , 2004 ; Tang et al. , 2003	41460
@NP	et al.	41460
@NP	2004 ; Tang et al.	41468
@NP	2004	41468
@NP	Tang et al.	41474
@NP	Tang	41474
@NP	et al.	41479
@NP	2003	41487
@NP	cell grafting	41505
@NP	1 week	41519
@NP	injury	41536
@NP	astrocyte reactivity and related expression of inhibitory molecules	41573
@NP	astrocyte reactivity and related expression	41573
@NP	inhibitory molecules	41620
@NP	The higher regeneration	41642
@NP	delayed OEC grafts in our rats	41696
@NP	delayed OEC grafts	41696
@NP	our rats	41718
@NP	part	41758
@NP	a more effective downregulation of these inhibitory factors	41767
@NP	a more effective downregulation	41767
@NP	these inhibitory factors	41802
@NP	OECs	41828
@NP	several growth factors	41861
@NP	the survival and regeneration	41897
@NP	different types	41930
@NP	neurons -LRB- Woodhall et al. , 2001 ; Lipson et al. , 2003 -RRB-	41949
@NP	neurons	41949
@NP	Woodhall	41958
@NP	et al. , 2001 ; Lipson et al. , 2003	41967
@NP	et al.	41967
@NP	2001 ; Lipson et al.	41975
@NP	2001	41975
@NP	Lipson et al.	41981
@NP	Lipson	41981
@NP	et al.	41988
@NP	2003	41996
@NP	The capabilities of OECs to promote and guide axonal regeneration	42003
@NP	The capabilities	42003
@NP	OECs to promote and guide axonal regeneration	42023
@NP	axonal regeneration	42049
@NP	several regions of the central nervous system	42095
@NP	several regions	42095
@NP	the central nervous system	42114
@NP	Transplants	42142
@NP	OECs	42166
@NP	the reentry of regenerating dorsal root axons into the dorsal horn	42178
@NP	the reentry	42178
@NP	dorsal root axons	42206
@NP	the dorsal horn	42229
@NP	the synapses	42249
@NP	sensory fibers	42285
@NP	functional restitution of spinal reflex arcs -LRB- Navarro et al. , 1999 -RRB-	42308
@NP	functional restitution	42308
@NP	spinal reflex arcs -LRB- Navarro et al. , 1999 -RRB-	42334
@NP	spinal reflex arcs	42334
@NP	Navarro	42354
@NP	et al. , 1999	42362
@NP	et al.	42362
@NP	1999	42370
@NP	the corticospinal tract	42382
@NP	OECs transplanted into the lesion site	42428
@NP	OECs	42428
@NP	the lesion site	42451
@NP	the elongation of corticospinal axons -LRB- Li et al. , 1998 -RRB-	42471
@NP	the elongation	42471
@NP	corticospinal axons -LRB- Li et al. , 1998 -RRB-	42489
@NP	corticospinal axons	42489
@NP	Li	42510
@NP	et al. , 1998	42513
@NP	et al.	42513
@NP	1998	42521
@NP	OECs	42528
@NP	relatively long distances	42558
@NP	the spinal cord	42605
@NP	the injured tissue -LRB- Boruch et al. , 2001 -RRB-	42636
@NP	the injured tissue	42636
@NP	Boruch	42656
@NP	et al. , 2001	42663
@NP	et al.	42663
@NP	2001	42671
@NP	the absence of a specific marker to label OECs	42685
@NP	the absence	42685
@NP	a specific marker to label OECs	42700
@NP	OECs	42727
@NP	we	42733
@NP	transplanted cells	42766
@NP	the spinal cord parenchyma	42814
@NP	9.5 months postinjury	42844
@NP	previous studies -LRB- Navarro et al. , 1999 ; Verdu ' et al. , 2001 -RRB-	42870
@NP	previous studies	42870
@NP	Navarro	42888
@NP	et al. , 1999 ; Verdu ' et al. , 2001	42896
@NP	et al.	42896
@NP	1999 ; Verdu ' et al.	42904
@NP	1999	42904
@NP	Verdu ' et al.	42910
@NP	Verdu '	42910
@NP	et al.	42917
@NP	2001	42925
@NP	we	42932
@NP	OECs pre-labeled with PKH26	42943
@NP	OECs	42943
@NP	PKH26	42965
@NP	the capabilities of those cells	42983
@NP	the capabilities	42983
@NP	those cells	43003
@NP	the injured spinal cord tissue	43041
@NP	the present study	43085
@NP	we	43104
@NP	transplanted cells	43121
@NP	it	43148
@NP	compounds	43183
@NP	the viability and phenotypic expression of cell markers , such as p75NTR ,	43200
@NP	the viability and phenotypic expression	43200
@NP	cell markers , such as p75NTR ,	43243
@NP	cell markers	43243
@NP	p75NTR	43265
@NP	glial cells -LRB- Mosahebi et al. , 2000 -RRB-	43276
@NP	glial cells	43276
@NP	Mosahebi	43289
@NP	et al. , 2000	43298
@NP	et al.	43298
@NP	2000	43306
@NP	they	43317
@NP	OECs	43335
@NP	other cells -LRB- Andrews and Stelzner , 2004 -RRB-	43343
@NP	other cells	43343
@NP	Andrews and Stelzner	43356
@NP	2004	43378
@NP	it	43395
@NP	chemical labeling distinctly	43415
@NP	chemical	43415
@NP	the 9-month-long follow-up in the grafted cells	43457
@NP	the 9-month-long follow-up	43457
@NP	the grafted cells	43487
@NP	OECs	43523
@NP	a gene reporter	43539
@NP	Cao et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003	43556
@NP	Cao	43556
@NP	et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003	43560
@NP	et al. , 2004	43560
@NP	et al.	43560
@NP	2004	43568
@NP	Ramer et al. , 2004a	43574
@NP	Ramer	43574
@NP	et al. , 2004a	43580
@NP	et al.	43580
@NP	2004a	43588
@NP	Ruitenberg et al. , 2003	43595
@NP	Ruitenberg	43595
@NP	et al. , 2003	43606
@NP	et al.	43606
@NP	2003	43614
@NP	immunostaining	43633
@NP	p75NTR	43652
@NP	Garcı ' a-Alı ' as et al. , 2004	43660
@NP	Garcı ' a-Alı	43660
@NP	et al.	43675
@NP	2004	43683
@NP	Plant et al. , 2003	43689
@NP	Plant	43689
@NP	et al. , 2003	43695
@NP	et al.	43695
@NP	2003	43703
@NP	Resnick et al. , 2003	43709
@NP	Resnick	43709
@NP	et al. , 2003	43717
@NP	et al.	43717
@NP	2003	43725
@NP	Ruitenberg et al. , 2003 ; Takami et al. ,	43731
@NP	Ruitenberg	43731
@NP	et al. , 2003 ; Takami et al. ,	43742
@NP	et al.	43742
@NP	2003 ; Takami et al.	43750
@NP	2003	43750
@NP	Takami et al.	43756
@NP	Takami	43756
@NP	et al.	43763
@NP	2002	43771
@NP	it	43778
@NP	OECs	43808
@NP	the spinal cord for at least 4 months after implantation	43836
@NP	the spinal cord	43836
@NP	at least 4 months after implantation	43856
@NP	at least 4 months	43856
@NP	implantation	43880
@NP	the present work	43897
@NP	we	43915
@NP	p75NTR-positive cells	43934
@NP	the spinal cord sections 9 months	43963
@NP	the spinal cord sections	43963
@NP	9 months	43988
@NP	injury	44003
@NP	Rubio et al. -LRB- 2002 -RRB-	44011
@NP	Rubio et al.	44011
@NP	Rubio	44011
@NP	et al.	44017
@NP	2002	44025
@NP	OECs	44045
@NP	p75 receptor	44065
@NP	time	44083
@NP	the lack of p75NTR-immunoreactive cells within the spinal cord parenchyma	44109
@NP	the lack	44109
@NP	p75NTR-immunoreactive cells within the spinal cord parenchyma	44121
@NP	p75NTR-immunoreactive cells	44121
@NP	the spinal cord parenchyma	44156
@NP	the death of the transplanted cells	44210
@NP	the death	44210
@NP	the transplanted cells	44223
@NP	the 9 months	44253
@NP	the fate of the transplanted cells over such a long time	44276
@NP	the fate	44276
@NP	the transplanted cells over such a long time	44288
@NP	the transplanted cells	44288
@NP	such a long time	44316
@NP	further investigation	44339
@NP	conclusion	44365
@NP	this work	44377
@NP	OEC grafts	44432
@NP	regeneration and partial functional recovery	44451
@NP	complete spinal cord transection	44502
@NP	acute transplantation of OECs	44551
@NP	acute transplantation	44551
@NP	OECs	44576
@NP	slightly better results	44590
@NP	1 week delayed transplantation	44619
@NP	1 week	44619
@NP	transplantation	44634
@NP	This	44651
@NP	a more suitable environment for axonal regeneration	44675
@NP	a more suitable environment	44675
@NP	axonal regeneration	44707
@NP	delayed grafting	44744
@NP	This study	44762
@NP	new insight	44782
@NP	the concept	44799
@NP	OECs	44816
@NP	a promising approach	44832
@NP	spinal cord injuries	44863
@NP	transplantation	44893
@NP	lesion	44934
@VP	shown electrophysiologically by return of motor	852
@VP	evoked potentials	900
@VP	indicating a more suitable environment for axonal regeneration	1296
@VP	were observed in rats receiving acute than delayed OEC transplants	1433
@VP	observed in rats receiving acute than delayed OEC transplants	1438
@VP	receiving acute than delayed OEC transplants	1455
@VP	obtained with transplantation after transection	1524
@VP	are encouraging for the application of OECs in the human injured spinal cord	1572
@VP	encouraging for the application of OECs in the human injured spinal cord	1576
@VP	to regenerate across the injury site	1838
@VP	regenerate across the injury site	1841
@VP	lead to permanent and irreversible deficits in the patients	1875
@VP	do not regenerate within the central nervous system	1951
@VP	regenerate within the central nervous system	1958
@VP	seem to be the main factors impeding axonal regeneration	2374
@VP	to be the main factors impeding axonal regeneration	2379
@VP	be the main factors impeding axonal regeneration	2382
@VP	impeding axonal regeneration	2402
@VP	is one of the experimental treatments that have provided promising results	2484
@VP	have provided promising results	2527
@VP	provided promising results	2532
@VP	transplanted into the partially injured spinal cord	2610
@VP	improve functional outcome	2662
@VP	underlying the neuroprotective/regenerative properties of OECs	2831
@VP	are not completely elucidated	2894
@VP	completely elucidated	2902
@VP	are considered the main beneficial actions	3233
@VP	considered the main beneficial actions	3237
@VP	may account for differences in the results	4118
@VP	account for differences in the results	4122
@VP	using OECs in human spinal cord injury	4215
@VP	are ongoing -LRB- Senior , 2002 -RRB-	4254
@VP	implies delayed grafting	4330
@VP	delayed grafting	4338
@VP	grafting	4346
@VP	caused by the injury	4804
@VP	finally , to observe functional recovery	4940
@VP	observe functional recovery	4952
@VP	derived from the new connections	4980
@VP	using electrophysiological , functional , and immunohistochemical techniques	5192
@VP	are transplanted either acutely or 1 week delayed after spinal cord transection	5331
@VP	transplanted either acutely or 1 week delayed after spinal cord transection	5335
@VP	transplanted	5335
@VP	acutely or 1 week delayed after spinal cord transection	5355
@VP	performed	5710
@VP	were approved by the Ethics Committee of our institution	5852
@VP	approved by the Ethics Committee of our institution	5857
@VP	were set up from 50 P22	5978
@VP	set up from 50 P22	5983
@VP	were removed	6205
@VP	removed	6210
@VP	was stripped off with fine forceps	6239
@VP	stripped off with fine forceps	6243
@VP	were chemically digested and mechanically dissociated	6288
@VP	chemically digested and mechanically dissociated	6293
@VP	chemically digested	6293
@VP	mechanically dissociated	6317
@VP	recovered by centrifugation	6364
@VP	seeded in flasks pre-coated with poly-l-lysine -LRB- 10 Ag/ml , Sigma , St.	6396
@VP	was used for expanding the OECs	6495
@VP	used for expanding the OECs	6499
@VP	expanding the OECs	6508
@VP	reaching confluence -LRB- 7 -- 9 days in vitro -RRB-	6534
@VP	pre-coated with goat anti-mouse IgG	6672
@VP	attached with mouse	6712
@VP	recognize the p75-NGF receptor	6800
@VP	resuspended in freezing medium -LRB- C-6295 , Sigma -RRB-	6859
@VP	transferred to -20 °C for 10 min , then to a deep freezer at -80 °C	6910
@VP	washed two times by centrifugation -LRB- 900 rpm , 7 min -RRB- in DMEM/F12	7036
@VP	resuspended in the same medium	7116
@VP	were transplanted within 2 h of thawing	7158
@VP	transplanted within 2 h of thawing	7163
@VP	were anesthetized with pentobarbital -LRB- 40 mg/kg , i.p. -RRB-	7466
@VP	to expose the T8 -- T9 thoracic spinal cord segments	7539
@VP	expose the T8 -- T9 thoracic spinal cord segments	7542
@VP	was completely transected at T8 using microscissors	7599
@VP	completely transected at T8 using microscissors	7603
@VP	using microscissors	7631
@VP	were carefully lifted up to verify complete transection	7682
@VP	lifted up to verify complete transection	7697
@VP	to verify complete transection	7707
@VP	verify complete transection	7710
@VP	connected to a Hamilton syringe	7864
@VP	received a total of 1,500,000 cells	8185
@VP	administered acutely , 30 min after the lesion -LRB- OECac group ; n = 8 -RRB-	8238
@VP	delayed 7 days -LRB- OECdl group ; n = 8 -RRB-	8309
@VP	distributed at the same	8390
@VP	coordinates at 30 min -LRB- DMac group ; n = 8 -RRB- or 7 days	8414
@VP	were kept under a 12-h light/dark cycle and received water and food ad libitum	8507
@VP	were kept under a 12-h light/dark cycle	8507
@VP	kept under a 12-h light/dark cycle	8512
@VP	received water and food ad libitum	8551
@VP	were expressed twice a day until reflex voiding of the bladder was established	8596
@VP	expressed twice a day until reflex voiding of the bladder was established	8601
@VP	was established	8659
@VP	established	8663
@VP	using the open-field walking test	8731
@VP	measuring the locomotor ability during 5 min	8766
@VP	observed the hindlimb movements of the rat	8955
@VP	was the mean value of both examiners	9209
@VP	inclined at 45 - , 60 -	9428
@VP	reaching a horizontal platform	9464
@VP	overcome was scored	9518
@VP	was scored	9527
@VP	scored	9531
@VP	overlying the motor area and the anode at the nose	10175
@VP	recorded from the contralateral gastrocnemius muscle	10231
@VP	were amplified , filtered ,	10297
@VP	amplified , filtered ,	10302
@VP	to measure the amplitude	10381
@VP	measure the amplitude	10384
@VP	evoked potentials	10429
@VP	applied	10472
@VP	To assess lumbar spinal reflexes	10616
@VP	assess lumbar spinal reflexes	10619
@VP	inserted percutaneously at the sciatic notch	10792
@VP	recorded by means of needle electrodes	10994
@VP	amplified	11034
@VP	was calculated	11213
@VP	calculated	11217
@VP	were able to regenerate across the lesion site	11507
@VP	to regenerate across the lesion site	11517
@VP	regenerate across the lesion site	11520
@VP	were anesthetized , placed in a stereotaxic frame	11710
@VP	placed in a stereotaxic frame	11729
@VP	were drilled into the cranium to expose both sensorimotor cortices	11774
@VP	drilled into the cranium to expose both sensorimotor cortices	11779
@VP	to expose both sensorimotor cortices	11804
@VP	expose both sensorimotor cortices	11807
@VP	using a 10-Al Hamilton syringe	12047
@VP	remained in place for 2 min after injection -LRB- Schucht et al. , 2002 -RRB-	12083
@VP	were removed	12506
@VP	removed	12511
@VP	cryoprotected in 30 %	12567
@VP	Am thickness	12715
@VP	collected onto gelatin-coated glass slides	12748
@VP	were dehydrated in ethanol and coverslipped with DPX -LRB- Fluka -RRB-	13866
@VP	dehydrated in ethanol and coverslipped with DPX -LRB- Fluka -RRB-	13871
@VP	dehydrated in ethanol	13871
@VP	coverslipped with DPX -LRB- Fluka -RRB-	13897
@VP	were processed as described with the omission of primary antibodies	13965
@VP	processed as described with the omission of primary antibodies	13970
@VP	described with the omission of primary antibodies	13983
@VP	occupying most of the dorso-ventral axis of the spinal cord	14041
@VP	attached to the microscope and then	14353
@VP	analyzed using NIH Image software for Apple Computers -LRB- version 1.6 -RRB-	14390
@VP	using NIH Image software for Apple Computers -LRB- version 1.6 -RRB-	14399
@VP	was measured -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2001 -RRB-	14796
@VP	measured -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2001 -RRB-	14800
@VP	separated by 135-µm intervals	14938
@VP	were processed for the above-indicated markers in each rat	14968
@VP	processed for the above-indicated markers in each rat	14973
@VP	was the mean obtained in 12 serial sections	15084
@VP	obtained in 12 serial sections	15097
@VP	was calculated as the average of each animal value	15164
@VP	calculated as the average of each animal value	15168
@VP	to reduce variability	15225
@VP	reduce variability	15228
@VP	were processed simultaneously for each marker	15283
@VP	processed simultaneously for each marker	15288
@VP	was the same for all the images	15368
@VP	were performed in a blinded manner regarding the treatment received by each rat	15486
@VP	performed in a blinded manner regarding the treatment received by each rat	15491
@VP	received by each rat	15545
@VP	are presented as the mean T SEM	15572
@VP	presented as the mean T SEM	15576
@VP	were made by nonparametric Kruskal -- Wallis and Mann -- Whitney U tests	15644
@VP	made by nonparametric Kruskal -- Wallis and Mann -- Whitney U tests	15649
@VP	were considered significant if P < 0.05	15724
@VP	considered significant if P < 0.05	15729
@VP	done to compare the proportion of rats showing MEPs restitution in each group	15965
@VP	to compare the proportion of rats showing MEPs restitution in each group	15970
@VP	compare the proportion of rats showing MEPs restitution in each group	15973
@VP	showing MEPs restitution in each group	16004
@VP	recorded in the gastrocnemius muscle , and of M - and H-waves	16094
@VP	recorded in the gastrocnemius muscle , and of M	16094
@VP	H-waves	16146
@VP	Note the change of vertical scale in recording A and recordings B -- F.	16457
@VP	disappeared	16545
@VP	did not return during the 9-month follow-up in DM-injected animals -LRB- B -RRB-	16561
@VP	return during the 9-month follow-up in DM-injected animals -LRB- B -RRB-	16569
@VP	H-waves	16984
@VP	showing the evolution of the H/M amplitude ratio over time -LRB- B -RRB-	17216
@VP	recovered versus the rats that did not recover MEPs in OECac and OECdl groups	17414
@VP	did not recover MEPs in OECac and OECdl groups	17445
@VP	recover MEPs in OECac and OECdl groups	17453
@VP	point to the transection site	17807
@VP	is at the left	17846
@VP	is a translucent tissue with a dark background at the site of transection	17899
@VP	is bridged by a whitish tissue	18051
@VP	bridged by a whitish tissue	18054
@VP	is at the left and caudal at the right	18111
@VP	is at the top and ventral at the bottom of the image	18158
@VP	bar = 5 mm	18218
@VP	= 5 mm	18222
@VP	showing absence of GFAP-positive tissue at the transection site	18312
@VP	increased GFAP labeling within the surrounding cord	18381
@VP	0.001 compared to group DMac ; # P < 0.05 , ## P <	18969
@VP	equals 1000 µm in panel A , 150 µm in panel B , and 100 µm in panel E.	19069
@VP	is at the left and caudal at the right	19708
@VP	is at the top and ventral at the bottom of the image	19755
@VP	0.01 compared to group DMdl , $ P < 0.05	19872
@VP	bar = 100 µm	19942
@VP	= 100 µm	19946
@VP	immunolabeled against ChAT , in green ; arrows	20087
@VP	appear in close contact with ChAT-immunoreactive motoneurons -LRB- insert -RRB-	20167
@VP	contacting with NG2-immunoreactive cells -LRB- F -RRB-	20444
@VP	bar = 100 µm	20496
@VP	= 100 µm	20500
@VP	show lesser hyperthophic morphology with thinner processes	20847
@VP	form a more aligned network than in DM-injected animals	20911
@VP	bar = 50 µm	21130
@VP	= 50 µm	21134
@VP	survived following injury	21156
@VP	died during the second surgery for delayed transplantation	21236
@VP	died or were sacrificed due to breast tumors after 6 months follow-up	21643
@VP	died	21643
@VP	were sacrificed due to breast tumors after 6 months follow-up	21651
@VP	sacrificed due to breast tumors after 6 months follow-up	21656
@VP	were 7 , 5 , 6 , and 5 in DMac , DMdl , OECac , and OECdl groups , respectively	21771
@VP	see Table	22005
@VP	were abolished	22055
@VP	abolished	22060
@VP	indicating complete interruption of spinal motor pathways -LRB- Fig. 1B -RRB-	22134
@VP	starting by 2	22270
@VP	recovered MEPs	22460
@VP	were not statistically different between OECac and OECdl groups	22475
@VP	were higher -LRB- P < 0.05 , chi-square test -RRB- than in DM groups	22549
@VP	recorded in regenerated animals	22652
@VP	consisted of multiple waves of low amplitude and long latency	22684
@VP	increased in amplitude	22764
@VP	shortened in latency	22788
@VP	tended to form single or polyphasic waves -LRB- Figs. 1E -- F -RRB-	22813
@VP	to form single or polyphasic waves -LRB- Figs. 1E -- F -RRB-	22820
@VP	form single or polyphasic waves -LRB- Figs. 1E -- F -RRB-	22823
@VP	received an acute OEC graft	22897
@VP	was 16.0 ± 2.1 ms and 17.6 ± 1.2 ms , respectively	23196
@VP	was about 7 -- 9 mV and that of the H-wave 250 -- 600 AV	23309
@VP	increased in all injured rats -LRB- Table 1 -RRB-	23487
@VP	injured rats -LRB- Table 1 -RRB-	23504
@VP	increased during the first 3 -- 4 months but remained stable afterwards	23669
@VP	increased during the first 3 -- 4 months	23669
@VP	remained stable afterwards	23711
@VP	was significantly reduced in group OECac during all the follow-up	23785
@VP	reduced in group OECac during all the follow-up	23803
@VP	showed normal locomotor activity scored as 21 on the BBB scale	24179
@VP	scored as 21 on the BBB scale	24212
@VP	was complete absence of hindlimb movements in all the rats -LRB- Fig. 2C -RRB-	24271
@VP	reaching a final average BBB score of 4.2 ± 0.7 points	24661
@VP	reaching a final average score of 3.7 ± 0.4 points -LRB- Fig. 2C -RRB-	24795
@VP	did not show MEPs recovery	24884
@VP	show MEPs recovery	24892
@VP	recovered MEPs	25002
@VP	were able to pass the highest angle -LRB- 90 ° -RRB- before injury	25345
@VP	to pass the highest angle -LRB- 90 ° -RRB- before injury	25355
@VP	pass the highest angle -LRB- 90 ° -RRB- before injury	25358
@VP	overcame the lowest inclination angle -LRB- 45 ° -RRB-	25463
@VP	achieved the platform with inclinations of 45 ° and 60 °	25563
@VP	were able to pass the inclined grid at 90 ° angle	25669
@VP	to pass the inclined grid at 90 ° angle	25679
@VP	pass the inclined grid at 90 ° angle	25682
@VP	achieved the maximal level	25747
@VP	were not the same in the different monthly tests	25774
@VP	bridged both cord stumps	26116
@VP	was identified as of meningeal origin	26188
@VP	identified as of meningeal origin	26192
@VP	was GFAP-negative	26227
@VP	were prominent -LRB- Fig. 4A -RRB-	26311
@VP	were found in the cranial and caudal stumps	26430
@VP	found in the cranial and caudal stumps	26435
@VP	were observed in the central scar	26514
@VP	observed in the central scar	26519
@VP	stopped at the scar interface -LRB- Fig. 4B -RRB-	26565
@VP	labeled axons	26665
@VP	being more abundant in group OECac -LRB- Figs. 4C -- D -RRB-	26720
@VP	identified by immunolabeling against CGRP	26785
@VP	grew in a dorsoventral orientation	27136
@VP	reached the cranial stump -LRB- Fig. 4F -RRB-	27190
@VP	To identify regenerated descending motor axons , the corticospinal tract	27407
@VP	identify regenerated descending motor axons , the corticospinal tract	27410
@VP	was anterogradely traced with BDA	27479
@VP	traced with BDA	27497
@VP	were visualized using immunohistochemistry for serotonin and DhOH , respectively	27588
@VP	visualized using immunohistochemistry for serotonin and DhOH , respectively	27593
@VP	using immunohistochemistry for serotonin and DhOH , respectively	27604
@VP	were mainly observed in ventral and ventrolateral aspects of the spinal cord	27835
@VP	observed in ventral and ventrolateral aspects of the spinal cord	27847
@VP	growing through to outermost part of the spinal cord -LRB- Figs. 5B -- C -RRB-	28063
@VP	crossed the caudal glial scar in DM-injected animals	28280
@VP	were observed at 1 mm from the rostral edge of the caudal stump	28426
@VP	observed at 1 mm from the rostral edge of the caudal stump	28431
@VP	receiving an OEC transplant	28558
@VP	regrown until lumbar segments of the spinal cord	28645
@VP	were mostly found in the central gray matter -LRB- laminae X and VIII -RRB-	28877
@VP	found in the central gray matter -LRB- laminae X and VIII -RRB-	28889
@VP	were also localized within the ventral gray matter	28960
@VP	appeared close to motoneurons -LRB- Figs. 6A -- C -RRB-	29015
@VP	were found between BBB score	29084
@VP	found between BBB score	29089
@VP	< 0.001	29260
@VP	< 0.001	29380
@VP	observed in the spinal cord parenchyma of any transplanted animal after 9 months	29656
@VP	followed a transverse orientation within the lesion epicenter	29952
@VP	did not cross the NG2 barrier	30097
@VP	cross the NG2 barrier	30105
@VP	to border NG2-immunoreactive cells -LRB- Figs. 6D -- F -RRB-	30162
@VP	border NG2-immunoreactive cells -LRB- Figs. 6D -- F -RRB-	30165
@VP	were seen within the lesion margins but rarely into the spinal cord parenchyma	30287
@VP	seen within the lesion margins but rarely into the spinal cord parenchyma	30292
@VP	tended to reduce NG2 immunoreactivity though not significantly	30573
@VP	to reduce NG2 immunoreactivity though not significantly	30580
@VP	reduce NG2 immunoreactivity though not significantly	30583
@VP	surrounding the lesion epicenter	30653
@VP	contained numerous hypertrophic interwoven GFAP-positive processes	30687
@VP	increased abruptly at the lesion margins and in the adjacent cord tissue	30800
@VP	diminished progressively from the lesion site	30878
@VP	had less hypertrophied morphology and thinner processes	30961
@VP	observed in DM-injected animals -LRB- Figs. 7C -- F -RRB-	31058
@VP	had signifi	31132
@VP	had intermediate values -LRB- Fig. 7B -RRB-	31277
@VP	delayed OEC transplantation into the	31388
@VP	transected spinal cord of adult rats	31436
@VP	promote long axonal regeneration and partial recovery of motor functions	31473
@VP	received an OEC transplant	31593
@VP	were observed in nontransplanted rats over the 9 months follow-up	31687
@VP	observed in nontransplanted rats over the 9 months follow-up	31692
@VP	were seen in OEC - than in DMinjected animals	32241
@VP	seen in OEC - than in DMinjected animals	32246
@VP	received an acute OEC transplant than in those with 1 week delayed transplant	32391
@VP	delayed transplant	32450
@VP	to repair the injured spinal cord	32988
@VP	repair the injured spinal cord	32991
@VP	regenerate across the lesion or to changes in spinal circuits	33084
@VP	caudal to the lesion -LRB- Fouad and Pearson , 2004 -RRB-	33146
@VP	grew through the lesion and projected caudally up to lumbar segments	33288
@VP	grew through the lesion	33288
@VP	projected caudally up to lumbar segments	33316
@VP	showed recovery of MEPs , but none of the control DM-injected rats	33465
@VP	to excite lumbar motoneurons -LRB- Konrad and Tacker , 1990 -RRB-	33663
@VP	excite lumbar motoneurons -LRB- Konrad and Tacker , 1990 -RRB-	33666
@VP	disappear because all descending tracts are disrupted	33755
@VP	are disrupted	33795
@VP	disrupted	33799
@VP	observed after OEC transplantation	34013
@VP	crossed the lesion site	34149
@VP	reappeared	34243
@VP	was due to return of descending control of hindlimb movements	34296
@VP	to return of descending control of hindlimb movements	34304
@VP	return of descending control of hindlimb movements	34307
@VP	climbing test by acute OEC transplantation after complete spinal cord	34432
@VP	observed in OEC-transplanted animals	34864
@VP	was only achieved in OEC-transplanted animals in which MEPs were restituted	35041
@VP	achieved in OEC-transplanted animals in which MEPs were restituted	35050
@VP	were restituted	35101
@VP	restituted	35106
@VP	found between BBB score	35154
@VP	presented higher reconnection and faster central conduction	35262
@VP	were found between motor recovery and density of descending motor axons	35355
@VP	found between motor recovery and density of descending motor axons	35360
@VP	regenerated caudal to the lesion	35427
@VP	shown by the H/M amplitude ratio	35568
@VP	becomes facilitated by interruption of supraspinal motor control	35728
@VP	facilitated by interruption of supraspinal motor control	35736
@VP	was progressive over time in DMinjected groups along the 9 months after injury	35824
@VP	corresponding with MEPs recovery	36054
@VP	modulate the previously facilitated reflex circuits at lumbar cord segments	36173
@VP	facilitated reflex circuits at lumbar cord segments	36197
@VP	induced a reduction in the H/M ratio even in rats in which MEPs did not recover	36298
@VP	did not recover	36362
@VP	recover	36370
@VP	might explain this fact -LRB- Verdu ' et al. , 2001	36489
@VP	explain this fact -LRB- Verdu ' et al. , 2001	36495
@VP	was supported by histological results	37006
@VP	supported by histological results	37010
@VP	indicating that more axonal fibers sprouted and regrew in transplanted animals	37222
@VP	sprouted and regrew in transplanted animals	37257
@VP	labeled sensory fibers	37361
@VP	turned caudally to the lesion site	37672
@VP	containing axons	37822
@VP	Descending coerulospinal	37887
@VP	invaded the caudal cord stump	37951
@VP	projected onto premotoneuronal pools	38047
@VP	would explain the recovery of MEPs	38207
@VP	explain the recovery of MEPs	38213
@VP	not studied in this work	38335
@VP	might also regenerate and contribute to recovery of motor responses	38361
@VP	regenerate and contribute to recovery of motor responses	38372
@VP	increased in amplitude and reduced their onset latency along time , at 9 months	38444
@VP	increased in amplitude	38444
@VP	reduced their onset latency along time , at 9 months	38471
@VP	walking behavior scored in the BBB scale	38759
@VP	scored in the BBB scale	38776
@VP	were not significant for most parameters	39047
@VP	delayed Schwann cell grafts	39283
@VP	reduced the size of cavitation in mildly injured spinal cords	39349
@VP	could be prevented by acute transplantation	39465
@VP	be prevented by acute transplantation	39471
@VP	prevented by acute transplantation	39474
@VP	produced a slight improvement	39794
@VP	was similar with both timings -LRB- Plant et al. , 2003 -RRB-	39859
@VP	exerted by OECs when they are transplanted acutely	39978
@VP	are transplanted acutely	40004
@VP	transplanted acutely	40008
@VP	delayed after spinal cord transection	40039
@VP	were transplanted either immediately after injury or delayed 4 weeks	40140
@VP	transplanted either immediately after injury or delayed 4 weeks	40145
@VP	transplanted either immediately after injury	40145
@VP	delayed 4 weeks	40193
@VP	grafted acutely	41090
@VP	repelling	41199
@VP	increase during the first week after spinal cord injury	41350
@VP	to prevent astrocyte reactivity and related expression of inhibitory molecules	41562
@VP	prevent astrocyte reactivity and related expression of inhibitory molecules	41565
@VP	observed following acute than delayed OEC grafts in our rats	41666
@VP	following acute than delayed OEC grafts in our rats	41675
@VP	to promote and guide axonal regeneration	42028
@VP	promote and guide axonal regeneration	42031
@VP	have been demonstrated in several regions of the central nervous system	42069
@VP	been demonstrated in several regions of the central nervous system	42074
@VP	demonstrated in several regions of the central nervous system	42079
@VP	guided the reentry of regenerating dorsal root axons into the dorsal horn	42171
@VP	regenerating dorsal root axons into the dorsal horn	42193
@VP	formed by regenerating sensory fibers	42262
@VP	regenerating sensory fibers	42272
@VP	was focally lesioned	42406
@VP	focally lesioned	42410
@VP	transplanted into the lesion site	42433
@VP	led the elongation of corticospinal axons -LRB- Li et al. , 1998 -RRB-	42467
@VP	transplanted in the spinal cord , mainly	42589
@VP	to label OECs	42718
@VP	label OECs	42721
@VP	survived and migrated within the spinal cord parenchyma at 9.5 months postinjury	42785
@VP	survived	42785
@VP	migrated within the spinal cord parenchyma at 9.5 months postinjury	42798
@VP	grafted OECs pre-labeled with PKH26	42935
@VP	pre-labeled with PKH26	42948
@VP	to survive and migrate in the injured spinal cord tissue	43015
@VP	survive and migrate in the injured spinal cord tissue	43018
@VP	diffuse from OECs to other cells -LRB- Andrews and Stelzner , 2004 -RRB-	43322
@VP	remains over the 9-month-long follow-up in the grafted cells	43444
@VP	using immunostaining for p75NTR	43627
@VP	survive and migrate in the spinal cord for at least 4 months after implantation	43813
@VP	reported that OECs down-regulated p75 receptor with time in vitro	44031
@VP	down-regulated p75 receptor with time in vitro	44050
@VP	needs further investigation	44333
@VP	delayed purified OEC grafts	44415
@VP	purified OEC grafts	44423
@VP	promoted slightly better results than 1 week delayed transplantation	44581
@VP	delayed transplantation	44626
@VP	to repair spinal cord injuries	44853
@VP	repair spinal cord injuries	44856
@VP	is shortly delayed after lesion	44909
@VP	delayed after lesion	44920
